| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | SPAST RSF1 ATP9B SMC5 HELB NAE1 DDX54 DDX43 DNAH9 HSPA5 DYNC1H1 SLC27A5 KIF2C HSP90AB1 KIF6 EP400 MYH7B MORC4 DNAH7 ATP6V0D1 MYO1F SMARCA2 DDX53 XRCC6 HELLS | 5.18e-07 | 614 | 260 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SPAST RSF1 ATP9B SMC5 HELB DDX54 DDX43 DNAH9 HSPA5 DYNC1H1 KIF2C HSP90AB1 KIF6 MORC4 DNAH7 DDX53 XRCC6 | 7.18e-05 | 441 | 260 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.58e-04 | 118 | 260 | 8 | GO:0003774 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | TEKT3 IFT140 CLUAP1 SPAST ARMC3 MAP1B KATNB1 FYCO1 FSIP2 DNAAF5 CCNYL1 DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 APOB PDCL2 DNAH7 MADD DYDC1 PCM1 | 6.48e-08 | 493 | 257 | 23 | GO:0007018 |
| GeneOntologyBiologicalProcess | microtubule-based process | TEKT3 IFT140 CLUAP1 SPAST ARMC3 MAP1B KATNB1 FYCO1 FSIP2 DNAAF5 CCDC13 CCNYL1 ZPR1 CLTC MAP3K11 DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 WASHC1 APOB PDCL2 SIK3 CHMP4B DNAH7 SIRT1 MADD DYDC1 WASH3P AKAP9 CDK5RAP2 PARD3 PCM1 | 1.34e-07 | 1058 | 257 | 35 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | METTL3 SPAST ACTR5 SMC5 BCR TRRAP UCHL5 ZPR1 NAE1 SVIL ANAPC2 CLTC TIMELESS TADA3 DYNC1H1 KIF2C HSP90AB1 BIN1 SRA1 EP400 PPP1R13B CHMP4B CREBBP GMNN SIRT1 HEXIM2 MADD CDK5RAP3 SMARCA2 ANKRD17 CDK5RAP2 SCRIB PBX1 CPSF3 HCFC1 | 6.76e-06 | 1256 | 257 | 35 | GO:0051726 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | SPAST MAP1B KATNB1 TMOD2 FYCO1 FAF2 VPS33B SVIL CLTC KLC1 KIF2C CARMIL1 APEH CHMP4B | 1.86e-05 | 291 | 257 | 14 | GO:0032984 |
| GeneOntologyBiologicalProcess | triglyceride mobilization | 3.72e-05 | 6 | 257 | 3 | GO:0006642 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CLUAP1 SPAST MAP1B KATNB1 FSIP2 DNAAF5 CCDC13 ZPR1 CLTC DYNC1H1 DYNC1LI2 KIF2C WASHC1 PDCL2 SIK3 CHMP4B DNAH7 SIRT1 WASH3P AKAP9 CDK5RAP2 PARD3 PCM1 | 3.76e-05 | 720 | 257 | 23 | GO:0000226 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | CLCN3 OTOF CLTC ARC BIN1 SYNE1 GRIK5 ARHGDIA RAB3GAP1 ATP6V0D1 DNM3 ERC2 SNAP25 SCRIB | 5.45e-05 | 321 | 257 | 14 | GO:0099003 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | IFT140 SPAST MAP1B ACTR5 KATNB1 TMOD2 FYCO1 SMC5 MYLK3 UCHL5 SVIL ANAPC2 CLTC DYNC1H1 BIN1 RAP1GDS1 SYNE1 CARMIL1 POT1 WASHC1 GRIK5 HUWE1 CHMP4B SIRT1 WASH3P OSBP RAB3GAP1 CELSR1 CDK5RAP3 AKAP9 MYO1F SMARCA2 ERC2 CDK5RAP2 | 6.43e-05 | 1342 | 257 | 34 | GO:0033043 |
| GeneOntologyBiologicalProcess | organelle localization | SPAST MAP1B KATNB1 FYCO1 VPS33B BRAT1 DYNC1H1 KIF2C TFEB BIN1 SYNE1 CHMP4B SIRT1 MADD RAB3GAP1 AKAP9 DNM3 CDK5RAP2 SNAP25 SCRIB PARD3 PCM1 | 7.52e-05 | 703 | 257 | 22 | GO:0051640 |
| GeneOntologyBiologicalProcess | endomembrane system organization | PI4K2B SPAST CLCN3 VPS33B OTOF CLTC PLEC BIN1 COG7 SYNE1 WASHC1 GRIK5 PDCL2 HUWE1 CHMP4B WASH3P OSBP RAB3GAP1 AKAP9 ERC2 SNAP25 | 1.12e-04 | 672 | 257 | 21 | GO:0010256 |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | CLCN3 OTOF CLTC BIN1 GRIK5 ARHGDIA RAB3GAP1 ATP6V0D1 DNM3 ERC2 SNAP25 SCRIB | 1.26e-04 | 264 | 257 | 12 | GO:0099504 |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 1.33e-04 | 40 | 257 | 5 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 1.33e-04 | 40 | 257 | 5 | GO:0032376 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 1.69e-04 | 42 | 257 | 5 | GO:0031112 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | ACTR5 TRRAP HELB UCHL5 TIMELESS TADA3 EP400 POT1 CREBBP SIRT1 SMARCA2 | 1.80e-04 | 234 | 257 | 11 | GO:0006282 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 TEKT3 SPAST MAP1B KATNB1 TMOD2 SYNC RYR1 RYR2 CEP170 SVIL CLTC MAP3K11 PLEC DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 BIN1 MYH7B SYNE1 CARMIL1 CHMP4B DNAH7 ARHGAP4 CDK5RAP3 MYO1F DNM3 CDK5RAP2 TNK2 MYOM2 EIF3A AHNAK2 | 1.77e-06 | 1179 | 261 | 35 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 TEKT3 SPAST MAP1B KATNB1 TMOD2 SYNC RYR1 RYR2 CEP170 SVIL CLTC MAP3K11 PLEC DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 BIN1 MYH7B SYNE1 CARMIL1 CHMP4B DNAH7 ARHGAP4 CDK5RAP3 MYO1F DNM3 CDK5RAP2 TNK2 MYOM2 EIF3A AHNAK2 | 2.06e-06 | 1187 | 261 | 35 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | TEKT3 SPAST MAP1B KATNB1 CEP170 SVIL CLTC MAP3K11 DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 CHMP4B DNAH7 ARHGAP4 CDK5RAP3 DNM3 CDK5RAP2 EIF3A | 3.85e-06 | 533 | 261 | 21 | GO:0005874 |
| GeneOntologyCellularComponent | distal axon | MAP1B KATNB1 TMOD2 TIAM2 CLCN3 ZPR1 KCNMA1 KLC1 HSP90AB1 BIN1 GRIK5 SIRT1 ARHGAP4 ATP6V0D1 ERC2 TNK2 SNAP25 PARD3 | 9.97e-06 | 435 | 261 | 18 | GO:0150034 |
| GeneOntologyCellularComponent | growth cone | MAP1B KATNB1 TMOD2 TIAM2 ZPR1 KLC1 HSP90AB1 SIRT1 ARHGAP4 ERC2 TNK2 SNAP25 PARD3 | 1.36e-05 | 245 | 261 | 13 | GO:0030426 |
| GeneOntologyCellularComponent | site of polarized growth | MAP1B KATNB1 TMOD2 TIAM2 ZPR1 KLC1 HSP90AB1 SIRT1 ARHGAP4 ERC2 TNK2 SNAP25 PARD3 | 1.91e-05 | 253 | 261 | 13 | GO:0030427 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NCOA3 PDE4A SPAST MAP1B ATP9B SYNC RYR1 TSTD1 NELL1 VPS33B PTPRR ZPR1 KCNMA1 TOLLIP ASPSCR1 PLEC HSP90AB1 SYNE1 SELENOM PPP1R13B ECE1 OSBP DNM3 CDK5RAP2 TNK2 SNAP25 SNX5 | 4.65e-05 | 934 | 261 | 27 | GO:0048471 |
| GeneOntologyCellularComponent | axon | SPAST MAP1B KATNB1 TMOD2 BCR RXRA TIAM2 CLCN3 ZPR1 KCNMA1 PLEC DYNC1H1 KLC1 HSP90AB1 BIN1 GRIK5 SIRT1 MADD ARHGAP4 ATP6V0D1 DNM3 ERC2 TNK2 SNAP25 PARD3 HCFC1 | 5.55e-05 | 891 | 261 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 TEKT3 SPAST MAP1B KATNB1 SYNC CEP170 SVIL CLTC MAP3K11 PLEC DNAH9 DYNC1H1 KLC1 DYNC1LI2 KIF2C KIF6 CARMIL1 CHMP4B DNAH7 ARHGAP4 CDK5RAP3 MYO1F DNM3 CDK5RAP2 EIF3A | 6.42e-05 | 899 | 261 | 26 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA3 ACTR5 RSF1 MED14 TRRAP RXRA HELB COPS7A WDR3 UCHL5 ANAPC2 CLTC NFYA TIMELESS TADA3 HSPA5 HSP90AB1 BIN1 EP400 SYNE1 POLR2A POT1 CHMP4B TSEN2 CREBBP SIRT1 POLR3C DYDC1 SMARCA2 PRPF38A PBX1 CPSF3 HCFC1 XRCC6 | 1.11e-04 | 1377 | 261 | 34 | GO:0140513 |
| GeneOntologyCellularComponent | extrinsic component of membrane | PDE4A RYR1 RYR2 CLTC TOLLIP BIN1 CDH24 AKAP9 FARP1 SNAP25 SCRIB | 1.58e-04 | 230 | 261 | 11 | GO:0019898 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.97e-04 | 161 | 261 | 9 | GO:0005875 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.63e-04 | 46 | 261 | 5 | GO:0005790 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.32e-04 | 137 | 261 | 8 | GO:0019897 | |
| GeneOntologyCellularComponent | INO80-type complex | 3.84e-04 | 28 | 261 | 4 | GO:0097346 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP1B BCR SEMA4C CLCN3 NAE1 CLTC KCNMA1 ARC PLCB4 KIF2C PRUNE2 BIN1 RASGRF2 GRIK5 GRM5 CHMP4B AKAP9 FARP1 DNM3 ERC2 SNAP25 SCRIB | 6.27e-04 | 817 | 261 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | ribbon synapse | 6.49e-04 | 32 | 261 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | sarcolemma | 6.63e-04 | 190 | 261 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | myofibril | TMOD2 SYNC RYR1 RYR2 SVIL PLEC BIN1 MYH7B SYNE1 MYOM2 AHNAK2 | 6.75e-04 | 273 | 261 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | centrosome | IFT140 CLUAP1 SPAST KATNB1 CEP170 CCDC13 MAP3K11 DYNC1H1 DYNC1LI2 KIF2C RBBP6 WASHC1 ECPAS TSEN2 WASH3P CDK5RAP3 ATP6V0D1 AKAP9 LRRCC1 CDK5RAP2 PCM1 | 7.08e-04 | 770 | 261 | 21 | GO:0005813 |
| GeneOntologyCellularComponent | 9+2 motile cilium | TEKT3 FSIP2 RSPH10B2 PCDH11X DNAH9 RSPH10B DNAH7 AK8 DYDC1 AKAP9 | 8.56e-04 | 238 | 261 | 10 | GO:0097729 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 9.17e-04 | 35 | 261 | 4 | GO:0099243 | |
| GeneOntologyCellularComponent | contractile muscle fiber | TMOD2 SYNC RYR1 RYR2 SVIL PLEC BIN1 MYH7B SYNE1 MYOM2 AHNAK2 | 1.10e-03 | 290 | 261 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | ATPase complex | 1.20e-03 | 129 | 261 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.30e-03 | 96 | 261 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 1.37e-03 | 18 | 261 | 3 | GO:0031083 | |
| GeneOntologyCellularComponent | cytoplasmic region | TEKT3 IFT140 SPAST ARC DNAH9 DYNC1H1 RSPH10B DNAH7 AK8 MADD DYDC1 ERC2 | 2.00e-03 | 360 | 261 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TEKT3 IFT140 SPAST ARC DNAH9 DYNC1H1 RSPH10B DNAH7 AK8 MADD DYDC1 | 2.23e-03 | 317 | 261 | 11 | GO:0032838 |
| HumanPheno | Delayed myelination | DOHH GLYCTK POGZ TRRAP CLCN3 NAE1 CLTC AHCY BRAT1 RAP1GDS1 COG7 POLR2A CREBBP GMNN MADD RAB3GAP1 HCFC1 | 3.53e-06 | 280 | 87 | 17 | HP:0012448 |
| HumanPheno | Abnormality of mouth size | IFT140 KATNB1 POGZ BCR TRRAP RYR1 CLCN3 KCNMA1 PLCB4 BIN1 COG7 HUWE1 WDR26 CREBBP GMNN MADD RAB3GAP1 IARS2 SMARCA2 LTBP3 | 2.11e-05 | 425 | 87 | 20 | HP:0011337 |
| HumanPheno | Delayed CNS myelination | DOHH GLYCTK POGZ TRRAP CLCN3 NAE1 CLTC BRAT1 RAP1GDS1 POLR2A MADD RAB3GAP1 HCFC1 | 2.66e-05 | 199 | 87 | 13 | HP:0002188 |
| HumanPheno | Motor delay | IFT140 KATNB1 POGZ SMC5 TRRAP RYR1 CLCN3 PMPCA AHCY PYCR1 PLEC BRAT1 DYNC1H1 BIN1 RAP1GDS1 SYNE1 POLR2A SPTLC1 HUWE1 SIK3 WDR26 TSEN2 CREBBP GMNN MADD RAB3GAP1 IARS2 SMARCA2 ANKRD17 CYP2U1 SNAP25 PBX1 CPSF3 HELLS | 2.76e-05 | 1018 | 87 | 34 | HP:0001270 |
| HumanPheno | Narrow mouth | POGZ BCR RYR1 CLCN3 PLCB4 BIN1 COG7 HUWE1 CREBBP GMNN MADD RAB3GAP1 IARS2 LTBP3 | 3.41e-05 | 234 | 87 | 14 | HP:0000160 |
| HumanPheno | Delayed ability to walk | TRRAP RYR1 CLCN3 PMPCA BRAT1 DYNC1H1 SYNE1 POLR2A SPTLC1 HUWE1 WDR26 CREBBP RAB3GAP1 SMARCA2 CYP2U1 SNAP25 | 4.30e-05 | 304 | 87 | 16 | HP:0031936 |
| HumanPheno | Neonatal respiratory distress | GLYCTK RYR1 DNAAF5 PLCB4 PLEC DNAH9 BIN1 COG7 MADD SNAP25 PBX1 | 5.21e-05 | 154 | 87 | 11 | HP:0002643 |
| HumanPheno | Underdeveloped nasal alae | 5.94e-05 | 104 | 87 | 9 | HP:0000430 | |
| HumanPheno | Abnormal nasal tip morphology | KATNB1 ZMYM2 POGZ SMC5 TRRAP RYR1 CLCN3 PYCR1 FRAS1 RAP1GDS1 HUWE1 ECE1 WDR26 MADD RAB3GAP1 SMARCA2 LTBP3 MAB21L1 | 6.70e-05 | 386 | 87 | 18 | HP:0000436 |
| HumanPheno | Thin vermilion border | KATNB1 POGZ BCR TRRAP CLCN3 CLTC KCNMA1 PYCR1 BRAT1 RAP1GDS1 HUWE1 WDR26 CREBBP RAB3GAP1 IARS2 SMARCA2 ANKRD17 CDK5RAP2 PBX1 | 9.28e-05 | 433 | 87 | 19 | HP:0000233 |
| HumanPheno | Microcephaly | IFT140 DOHH MAP1B KATNB1 GLYCTK ZMYM2 POGZ SMC5 BCR TRRAP CLCN3 VPS33B ZPR1 DGUOK CLTC AHCY KCNMA1 PYCR1 BRAT1 DYNC1H1 FRAS1 RAP1GDS1 OTUD5 COG7 SYNE1 POLR2A SPTLC1 HUWE1 WDR26 TSEN2 CREBBP GMNN RAB3GAP1 SMARCA2 ANKRD17 CDK5RAP2 CPSF3 HCFC1 MAB21L1 | 1.32e-04 | 1341 | 87 | 39 | HP:0000252 |
| HumanPheno | Decreased head circumference | IFT140 DOHH MAP1B KATNB1 GLYCTK ZMYM2 POGZ SMC5 BCR TRRAP CLCN3 VPS33B ZPR1 DGUOK CLTC AHCY KCNMA1 PYCR1 BRAT1 DYNC1H1 FRAS1 RAP1GDS1 OTUD5 COG7 SYNE1 POLR2A SPTLC1 HUWE1 WDR26 TSEN2 CREBBP GMNN RAB3GAP1 SMARCA2 ANKRD17 CDK5RAP2 CPSF3 HCFC1 MAB21L1 | 1.66e-04 | 1354 | 87 | 39 | HP:0040195 |
| Pathway | PID_RAC1_REG_PATHWAY | 1.13e-05 | 38 | 192 | 6 | M241 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 CAAP1 MATR3 MED14 ZMYM2 POGZ TRRAP CCNYL1 SVIL CLTC TIMELESS PLEC DYNC1LI2 HSP90AB1 BIN1 EP400 KDM5A OTUD5 RBBP6 CARMIL1 POLR2A USP24 ZNF507 PATL1 HUWE1 ECPAS IFI16 SIRT1 HEXIM2 ZNF106 OSBP GTF3C1 SMARCA2 ANKRD17 ELF1 PRPF38A SCRIB PARD3 XRCC6 PCM1 | 1.65e-21 | 774 | 267 | 40 | 15302935 |
| Pubmed | SPAST PEG3 ZMYM2 SYNC POGZ USP9Y WDR3 NELL1 CCDC13 OTOF CLTC AHCY MAP3K11 TOLLIP GFPT2 PLEC HSPA5 DYNC1H1 HSP90AB1 USP13 BIN1 RAP1GDS1 KDM5A SYNE1 APEH OAT HUWE1 WDR26 CREBBP MADD GMCL1 THOP1 DNM3 LRRCC1 ERC2 CD74 LTBP3 SNAP25 SCRIB PBX1 PBX2 DKK3 XRCC6 PCM1 SCAI SNX5 | 2.78e-18 | 1285 | 267 | 46 | 35914814 | |
| Pubmed | NCOA3 PDE4A MATR3 ZMYM2 FYCO1 BCR MAP3K5 CEP170 CCDC13 SVIL CLTC KCNMA1 ARC DYNC1H1 KLC1 KIF2C HSP90AB1 CACNB2 BIN1 KDM5A SYNE1 GRIK5 HUWE1 SIK3 GRM5 WDR26 AKAP9 FARP1 DNM3 ANKRD17 ERC2 CDK5RAP2 SCRIB PARD3 XRCC6 PCM1 | 5.16e-15 | 963 | 267 | 36 | 28671696 | |
| Pubmed | NCOA3 ACTR5 MATR3 KCMF1 BMS1 ZMYM2 TMOD2 POGZ TRRAP RXRA UCHL5 SVIL NFKBIA DDX54 NFYA GFPT2 TADA3 DYNC1H1 EP400 KDM5A RBBP6 ZNF507 PPP1R13B PATL1 MORC4 CHMP4B CREBBP SIRT1 HEXIM2 ZNF3 TIMM10 GTF3C1 SMARCA2 ANKRD17 ELF1 EIF3A PBX1 PBX2 HCFC1 XRCC6 PCM1 HELLS | 8.33e-14 | 1429 | 267 | 42 | 35140242 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MCMBP HGH1 KCMF1 RSU1 COPS7A DNAAF5 UCHL5 ZPR1 NAE1 AHCY TOLLIP GMDS TIMELESS ASPSCR1 PLEC BRAT1 HSPA5 DYNC1H1 KLC1 DYNC1LI2 HSP90AB1 PRUNE2 BIN1 RAP1GDS1 COG7 POLR2A USP24 APEH RANBP6 HUWE1 ECPAS WDR26 TSEN2 SIRT1 OSBP RAB3GAP1 THOP1 EIF3A HCFC1 XRCC6 SNX5 AHNAK2 | 1.51e-13 | 1455 | 267 | 42 | 22863883 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MCMBP SPAST MAP1B MATR3 TSSK2 BCR CEP170 FSIP2 MYLK3 SVIL PLEC KLC1 KIF2C TFEB SASH1 KDM5A CARMIL1 SIK3 WDR26 DNAH7 MADD ZNF106 AKAP9 FRMD6 ANKRD17 FAM53B SCRIB PARD3 FGD6 PCM1 DOP1A AHNAK2 | 2.23e-13 | 861 | 267 | 32 | 36931259 |
| Pubmed | IFT140 ZMYM2 POGZ MAP3K5 CLTC NFYA MAP3K11 TOLLIP PLEC HSPA5 HSP90AB1 RAP1GDS1 RBBP6 SYNE1 PPP1R13B SIK3 CREBBP MADD ARHGDIA ZNF106 ANKRD17 TNK2 EIF3A WASH2P | 7.33e-13 | 486 | 267 | 24 | 20936779 | |
| Pubmed | NCOA3 METTL3 MCMBP MATR3 RSF1 MED14 SMC5 TRRAP RXRA WDR3 UCHL5 NAE1 PLEC BRAT1 TADA3 USP13 EP400 RBBP6 POLR2A ECPAS IFI16 WDR26 CREBBP SIRT1 POLR3C ARHGDIA GTF3C1 SMARCA2 EIF3A CPSF3 HCFC1 XRCC6 HELLS | 3.39e-12 | 1014 | 267 | 33 | 32416067 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B MATR3 RSF1 BMS1 SRPK1 POGZ TRRAP WDR3 FAF2 VPS33B CLTC DDX54 AHCY PYCR1 DDX43 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 POLR2A HUWE1 IFI16 CREBBP ARHGDIA RAB3GAP1 GTF3C1 LTN1 SMARCA2 ANKRD17 EIF3A PRPF38A SCRIB PARD3 CPSF3 XRCC6 AHNAK2 | 5.64e-12 | 1353 | 267 | 38 | 29467282 |
| Pubmed | PI4K2B CLGN MAP1B BMS1 SRPK1 ARHGAP11A CEP170 WDR3 DNAAF5 FAF2 CLTC DDX54 PYCR1 DYNC1H1 COG7 SPTLC1 RANBP6 OAT HUWE1 ECPAS CHMP4B IFI16 WDR26 IFIT1 ARHGDIA RAB3GAP1 IARS2 ATP6V0D1 GTF3C1 LTN1 CD74 EIF3A SNAP25 SCRIB HCFC1 XRCC6 PCM1 AHNAK2 HELLS | 8.59e-12 | 1440 | 267 | 39 | 30833792 | |
| Pubmed | MAP1B RSF1 BMS1 SRPK1 POGZ TRRAP CEP170 WDR3 CLTC DDX54 PLEC DYNC1H1 POLR2A USP24 OAT HUWE1 ECPAS ARHGDIA IARS2 GTF3C1 SMARCA2 ANKRD17 CPSF3 HCFC1 XRCC6 PCM1 | 1.00e-11 | 653 | 267 | 26 | 22586326 | |
| Pubmed | NCOA3 METTL3 MCMBP RSF1 ZMYM2 ANAPC2 MAP3K11 TIMELESS BRAT1 KLC1 DYNC1LI2 HSP90AB1 RBBP6 USP24 HUWE1 IFI16 SIRT1 GTF3C1 ELF1 SCRIB HCFC1 PCM1 | 7.15e-11 | 503 | 267 | 22 | 16964243 | |
| Pubmed | CAAP1 SPAST KCMF1 RSU1 COPS7A NFKBIA ASPSCR1 PLEC BRAT1 HSPA5 HSP90AB1 HUWE1 POLR3C RAB3GAP1 GTF3C1 DNM3 HELLS | 1.18e-10 | 288 | 267 | 17 | 23383273 | |
| Pubmed | NCOA3 SPAST MED14 ZMYM2 POGZ TRRAP CEP170 NAE1 CLTC AHCY TADA3 DYNC1H1 KIF2C EP400 LCORL ZNF507 APEH ECPAS CHMP4B IFI16 CREBBP GMNN SIRT1 ZNF3 ARHGDIA GTF3C1 SMARCA2 ELF1 HCFC1 XRCC6 PCM1 HELLS | 1.39e-10 | 1103 | 267 | 32 | 34189442 | |
| Pubmed | MCMBP HGH1 MATR3 RSF1 SRPK1 FYCO1 SYNC FAF2 DDX54 GFPT2 HSPA5 KLC1 FRAS1 RBBP6 POLR2A PATL1 ECPAS IFIT1 POLR3C OSBP SCRIB CPSF3 XRCC6 HELLS | 3.28e-10 | 653 | 267 | 24 | 33742100 | |
| Pubmed | MAP1B MATR3 MED14 POGZ TRRAP CEP170 CLTC HSPA5 DYNC1H1 KLC1 EP400 RBBP6 POLR2A USP24 PPP1R13B HUWE1 CREBBP GTF3C1 SCRIB PARD3 HCFC1 PCM1 | 3.73e-10 | 549 | 267 | 22 | 38280479 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MAP1B KCMF1 ZMYM2 BCR PMPCA SVIL RBBP6 POLR2A HUWE1 IARS2 ATP6V0D1 GTF3C1 LTN1 SCRIB PARD3 CPSF3 HCFC1 | 4.25e-10 | 313 | 267 | 17 | 38270169 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | MATR3 ZMYM2 POGZ SMC5 COPS7A CEP170 SVIL ANAPC2 CLTC AHCY TIMELESS DYNC1H1 DYNC1LI2 COG7 SYNE1 CARMIL1 POLR2A PATL1 CHMP4B TSEN2 GMNN SIRT1 ZNF106 GTF3C1 MOB1A SMARCA2 CDK5RAP2 EIF3A SCRIB HCFC1 XRCC6 PCM1 | 4.36e-10 | 1155 | 267 | 32 | 20360068 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B BMS1 ZMYM2 POGZ TRRAP RXRA NFKBIA AHCY NFYA DYNC1H1 KIF2C HSP90AB1 EP400 KDM5A POLR2A HUWE1 ECPAS CREBBP HEXIM2 IARS2 GTF3C1 ANKRD17 SCRIB PBX1 PBX2 HCFC1 HELLS | 7.26e-10 | 857 | 267 | 27 | 25609649 |
| Pubmed | NCOA3 RSF1 ZMYM2 RYR1 RYR2 FAF2 PYCR1 GFPT2 POT1 USP24 SIK3 MORC4 IFIT1 CREBBP DNAH7 DYDC1 OSBP RAB3GAP1 SMARCA2 ANKRD17 CDK5RAP2 AHNAK2 HELLS | 1.13e-09 | 638 | 267 | 23 | 31182584 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1B MED14 TRRAP FAF2 VPS33B CLTC AHCY TIMELESS DYNC1H1 KLC1 POLR2A SPTLC1 GRIK5 HUWE1 RAB3GAP1 IARS2 CDK5RAP3 GTF3C1 LTN1 SMARCA2 ANKRD17 PRPF38A SCRIB HCFC1 | 1.46e-09 | 704 | 267 | 24 | 29955894 |
| Pubmed | MATR3 PEG3 TIAM2 COPS7A VPS33B PTPRR CLTC TOLLIP CRYBG1 TIMELESS GFPT2 PLEC DYNC1LI2 KIF2C CACNB2 ZNF507 APOB PATL1 HUWE1 MADD CDK5RAP3 THOP1 ZNF341 FARP1 LTN1 ANKRD17 CDK5RAP2 PRPF38A PARD3 SNX5 | 1.64e-09 | 1084 | 267 | 30 | 11544199 | |
| Pubmed | HGH1 BMS1 SRPK1 TRRAP CEP170 WDR3 DNAAF5 CLTC AHCY TOLLIP PLCB4 BRAT1 HSPA5 DYNC1H1 HSP90AB1 RBBP6 USP24 SPTLC1 APEH OAT APOB ECE1 ARHGDIA ZNF106 THOP1 ATP6V0D1 MOB1A EIF3A CPSF3 HCFC1 XRCC6 PCM1 HELLS | 1.92e-09 | 1297 | 267 | 33 | 33545068 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SDSL PDE4A ANKS6 MED14 FYCO1 BCR TRRAP RYR1 TIAM2 MAP3K5 ARC MAP3K11 PLEC BRAT1 DYNC1H1 TFEB FRAS1 EP400 POLR2A APEH HUWE1 ECE1 MADD CELSR1 ZNF341 TNK2 LTBP3 LTK HCFC1 AHNAK2 | 2.55e-09 | 1105 | 267 | 30 | 35748872 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CLGN MAP1B SRPK1 BCR TRRAP RSU1 CEP170 ANAPC2 AHCY MAP3K11 DDX43 PLEC HSPA5 KLC1 OAT SIK3 WDR26 CREBBP GMNN HEXIM2 AKAP9 GTF3C1 MOB1A DNM3 CDK5RAP2 TNK2 SCAI | 2.63e-09 | 910 | 267 | 27 | 36736316 |
| Pubmed | MCMBP MATR3 KCMF1 MED14 SRPK1 RXRA SVIL CLTC DDX54 AHCY TOLLIP HSPA5 DYNC1H1 KLC1 DYNC1LI2 HSP90AB1 RBBP6 POLR2A APEH OAT PATL1 HUWE1 HEXIM2 THOP1 AKAP9 IGFBP4 SMARCA2 ANKRD17 PARD3 HCFC1 XRCC6 HELLS | 2.81e-09 | 1247 | 267 | 32 | 27684187 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP1B ATP9B BCR TRRAP RSU1 RXRA CEP170 DNAAF5 PTPRG PTPRR SEL1L3 KCNMA1 ASPSCR1 PLCB4 PRUNE2 CACNB2 CARMIL1 PATL1 HUWE1 ECPAS TSEN2 CREBBP HEXIM2 THOP1 GTF3C1 FARP1 SMARCA2 ANKRD17 TNK2 GREB1 PBX1 PARD3 PBX2 PCM1 DOP1A | 4.57e-09 | 1489 | 267 | 35 | 28611215 |
| Pubmed | EFCAB5 MCMBP HGH1 NUTM2A DNAAF5 FAF2 PMPCA UCHL5 ZPR1 NAE1 CLTC AHCY BRAT1 HSPA5 DYNC1H1 HSP90AB1 RAP1GDS1 MYH7B USP24 SPTLC1 OAT HUWE1 ECPAS SIRT1 IARS2 XRCC6 | 5.48e-09 | 878 | 267 | 26 | 37223481 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CAAP1 MAP1B MATR3 BMS1 MED14 ZMYM2 POGZ USP9Y LRCH1 TRRAP CEP170 CLTC PLEC HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 EP400 KDM5A RBBP6 SYNE1 POLR2A SIK3 GTF3C1 FARP1 DNM3 PRPF38A CPSF3 XRCC6 | 6.36e-09 | 1082 | 267 | 29 | 38697112 |
| Pubmed | CAAP1 MATR3 PEG3 NUTM2A BMS1 SRPK1 POGZ RSU1 CEP170 WDR3 UCHL5 SVIL CLTC AHCY PYCR1 PLEC DYNC1H1 HSP90AB1 EP400 KDM5A APOB PATL1 CHMP4B HEXIM2 ARHGDIA AKAP9 FARP1 ANKRD17 PRPF38A PARD3 HCFC1 XRCC6 PCM1 | 7.44e-09 | 1371 | 267 | 33 | 36244648 | |
| Pubmed | PI4K2B MATR3 KATNB1 MED14 FYCO1 BCR CLCN3 CLTC DDX54 MAP3K11 BRAT1 HSPA5 DYNC1H1 KLC1 DYNC1LI2 KIF2C HSP90AB1 HUWE1 ECPAS ECE1 IFI16 CDK5RAP3 GTF3C1 ANKRD17 TNK2 CD74 EIF3A HCFC1 XRCC6 PCM1 | 8.97e-09 | 1168 | 267 | 30 | 19946888 | |
| Pubmed | BMS1 ZMYM2 POGZ TRRAP TADA3 EP400 POLR2A ZNF507 GMNN POLR3C GTF3C1 ELF1 PRPF38A HCFC1 XRCC6 HELLS | 1.04e-08 | 339 | 267 | 16 | 30415952 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MCMBP CLGN MATR3 BMS1 SRPK1 BCR DNAAF5 FAF2 PMPCA PTPRR DDX54 PYCR1 HSPA5 KIF2C RANBP6 OAT HUWE1 ECPAS WDR26 SIRT1 THOP1 GTF3C1 LTN1 MOB1A ANKRD17 EIF3A PCM1 | 1.09e-08 | 974 | 267 | 27 | 28675297 |
| Pubmed | PEG3 RSU1 RYR1 MAP3K5 CEP170 CLTC PLEC HSP90AB1 BIN1 RASGRF2 KDM5A SYNE1 AKAP9 CDK5RAP2 MYOM2 EIF3A PARD3 XRCC6 SNX5 | 1.31e-08 | 497 | 267 | 19 | 23414517 | |
| Pubmed | MCMBP BMS1 SRPK1 RSU1 WDR3 FAF2 PMPCA NAE1 CLTC DDX54 PYCR1 GMDS TADA3 HSPA5 KLC1 FRAS1 SYNE1 SPTLC1 APEH OAT SIK3 SIRT1 RAB3GAP1 IARS2 CDK5RAP3 AKAP9 FARP1 CDK5RAP2 SCRIB PARD3 XRCC6 PCM1 SNX5 HELLS | 1.53e-08 | 1487 | 267 | 34 | 33957083 | |
| Pubmed | MATR3 MED14 ZMYM2 CEP170 WDR3 VPS33B ANAPC2 CLTC TIMELESS HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 COG7 ECPAS RAB3GAP1 CDK5RAP3 ATP6V0D1 LTN1 HCFC1 | 1.66e-08 | 560 | 267 | 20 | 35241646 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MCMBP MATR3 BMS1 POGZ WDR3 FAF2 PMPCA VPS33B UCHL5 CLTC DDX54 AHCY PYCR1 HSPA5 DYNC1H1 HSP90AB1 SYNE1 POLR2A SPTLC1 OAT APOB HUWE1 ECPAS CHMP4B ARHGDIA IARS2 ATP6V0D1 GTF3C1 EIF3A CPSF3 HCFC1 XRCC6 HELLS | 1.88e-08 | 1425 | 267 | 33 | 30948266 |
| Pubmed | PEG3 POGZ SMC5 FAF2 ZFR2 CLTC SEL1L3 HERC3 DYNC1H1 FRAS1 EP400 SYNE1 MADD AKAP9 DNM3 ERC2 SCRIB | 2.16e-08 | 407 | 267 | 17 | 12693553 | |
| Pubmed | WDR3 DNAAF5 FAF2 CLTC PYCR1 PLEC HSPA5 DYNC1H1 HSP90AB1 COG7 POLR2A USP24 HUWE1 ECPAS WDR26 MOB1A EIF3A SCRIB CPSF3 XRCC6 HELLS | 2.93e-08 | 638 | 267 | 21 | 33239621 | |
| Pubmed | NCOA3 ZMYM2 POGZ BCR PLEC KLC1 KDM5A LCORL USP24 ZNF507 HUWE1 MORC4 ECPAS WDR26 GTF3C1 ANKRD17 PCM1 | 3.18e-08 | 418 | 267 | 17 | 34709266 | |
| Pubmed | IFT140 SPAST MATR3 BMS1 POGZ ARHGAP11A BCR LRCH1 TIAM2 ANAPC2 SASH1 EP400 ZNF507 SIK3 ECPAS ARHGAP4 ANKRD17 CDK5RAP2 FAM53B | 3.51e-08 | 529 | 267 | 19 | 14621295 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | METTL3 MCMBP ZMYM2 BCR COPS7A CLTC KIF2C TFEB EP400 OTUD5 RBBP6 ZNF507 PPP1R13B HUWE1 MORC4 CREBBP SIRT1 POLR3C ERC2 PCM1 | 3.71e-08 | 588 | 267 | 20 | 38580884 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAAP1 DOHH MATR3 KCMF1 BMS1 SRPK1 WDR3 CLTC DDX54 PYCR1 CRYBG1 DDX43 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 KDM5A RBBP6 USP24 SPTLC1 OAT PATL1 HUWE1 SMARCA2 EIF3A PRPF38A CPSF3 HCFC1 XRCC6 | 3.72e-08 | 1318 | 267 | 31 | 30463901 |
| Pubmed | MATR3 CEP170 PMPCA UCHL5 AHCY PYCR1 HSPA5 DYNC1H1 POLR2A APEH OAT HUWE1 WDR26 POLR3C ARHGDIA GTF3C1 ANKRD17 EIF3A SCRIB | 4.07e-08 | 534 | 267 | 19 | 35032548 | |
| Pubmed | ANKS6 BMS1 RYR2 SEMA4C WDR3 FAF2 NFKBIA CLTC DYNC1H1 DYNC1LI2 EP400 APEH APOB HUWE1 DNAH7 AK8 IARS2 FRMD6 CDK5RAP2 SCRIB PARD3 PCM1 HELLS | 4.38e-08 | 777 | 267 | 23 | 35844135 | |
| Pubmed | IFT140 CAAP1 PNMA1 ACTR5 RSF1 POGZ BCR TRRAP CEP170 TADA3 EP400 KDM5A RBBP6 POLR2A SPTLC1 ZKSCAN2 SIK3 WDR26 CREBBP SIRT1 ARHGAP4 LTN1 SMARCA2 ANKRD17 SCRIB LTK PARD3 PCM1 | 4.74e-08 | 1116 | 267 | 28 | 31753913 | |
| Pubmed | MCMBP BMS1 PTPRG PMPCA VPS33B PTPRR UCHL5 SVIL CLTC DDX54 KCNMA1 PYCR1 HSPA5 HSP90AB1 POLR2A PPP1R13B HUWE1 MADD AKAP9 FARP1 LTN1 MOB1A CDK5RAP2 PRPF38A SCRIB CPSF3 HELLS | 5.00e-08 | 1049 | 267 | 27 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KATNB1 BCR RSU1 WDR3 VPS33B SVIL PLEC DYNC1H1 KLC1 DYNC1LI2 HSP90AB1 CARMIL1 ZNF507 PPP1R13B PATL1 SIK3 ECPAS ECE1 DNAH7 IARS2 FARP1 LRRCC1 RINL PCM1 | 5.67e-08 | 853 | 267 | 24 | 28718761 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | HGH1 KCMF1 USP9Y SMC5 TRRAP COPS7A DDX54 PLCB4 KIF2C RASGRF2 CARMIL1 POLR2A ECPAS ZNF106 GTF3C1 MYOM2 HCFC1 HELLS | 7.16e-08 | 497 | 267 | 18 | 36774506 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SPAST MAP1B KATNB1 TMOD2 CEP170 FAF2 SVIL DYNC1LI2 BIN1 POLR2A USP24 APEH ECPAS CHMP4B FARP1 SCRIB HCFC1 XRCC6 | 7.38e-08 | 498 | 267 | 18 | 36634849 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B MATR3 RSF1 ZMYM2 CEP170 AHCY KLC1 HSP90AB1 EP400 RBBP6 CARMIL1 POLR2A OAT CHMP4B ARHGDIA IARS2 ANKRD17 EIF3A SCRIB CPSF3 HCFC1 XRCC6 PCM1 AHNAK2 HELLS | 7.69e-08 | 934 | 267 | 25 | 33916271 |
| Pubmed | SRPK1 LRCH1 FAF2 VPS33B CLTC AHCY CIAO2A DYNC1H1 HSP90AB1 SPTLC1 HUWE1 GTF3C1 FARP1 MOB1A HCFC1 XRCC6 | 9.86e-08 | 399 | 267 | 16 | 37536630 | |
| Pubmed | SDSL SRPK1 COPS7A CEP170 DNAAF5 SVIL CLTC DDX54 AHCY PYCR1 POLR2A ECPAS ZNF106 IARS2 ATP6V0D1 FRMD6 SMARCA2 XRCC6 PCM1 SNX5 | 1.25e-07 | 634 | 267 | 20 | 34591612 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MAP1B ACTR5 SRPK1 TRRAP WDR3 DDX54 FRAS1 EP400 IFI16 ZNF106 CDK5RAP3 GTF3C1 SMARCA2 DNM3 SCRIB HCFC1 | 1.42e-07 | 410 | 267 | 16 | 26949251 |
| Pubmed | MCMBP MAP1B MATR3 PEG3 SRPK1 BCR TRRAP COPS7A FAF2 PMPCA UCHL5 NAE1 ANAPC2 CLTC AHCY PYCR1 HSPA5 HSP90AB1 POLR2A WASHC1 SPTLC1 RANBP6 HUWE1 WDR26 SIRT1 ARHGDIA GTF3C1 EIF3A HCFC1 XRCC6 | 1.67e-07 | 1335 | 267 | 30 | 29229926 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | MAP1B MATR3 KCMF1 CEP170 CLTC AHCY PLEC DYNC1H1 HUWE1 ECPAS PCM1 | 1.87e-07 | 182 | 267 | 11 | 31067453 |
| Pubmed | CYP11A1 ZMYM2 RXRA RYR2 ANAPC2 PLEC DYNC1H1 USP13 SASH1 RBBP6 PPP1R13B RANBP6 HUWE1 MORC4 CREBBP ZNF106 ZNF341 LTBP3 XRCC6 | 1.95e-07 | 591 | 267 | 19 | 15231748 | |
| Pubmed | KRT72 KCMF1 CLCN3 HSPA5 KLC1 HSP90AB1 HUWE1 ECPAS IARS2 CDK5RAP3 SMARCA2 CPSF3 | 2.01e-07 | 225 | 267 | 12 | 25277244 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | METTL3 ACTR5 MATR3 RSF1 MED14 SRPK1 POGZ TRRAP MAP3K5 CLTC DYNC1H1 KIF2C POLR2A RANBP6 POLR3C GTF3C1 SMARCA2 HELLS | 2.02e-07 | 533 | 267 | 18 | 30554943 |
| Pubmed | KRT72 MAP1B MATR3 TMOD2 BCR CEP170 SVIL CLTC TOLLIP PLEC HSPA5 DYNC1H1 KLC1 HSP90AB1 CACNB2 BIN1 RAP1GDS1 SYNE1 CARMIL1 OAT GRM5 MADD ARHGDIA ATP6V0D1 FARP1 LRRCC1 ERC2 EIF3A SCRIB PCM1 SCAI | 2.28e-07 | 1431 | 267 | 31 | 37142655 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 2.32e-07 | 8 | 267 | 4 | 10655549 | |
| Pubmed | DOHH ARHGAP11A PTPRR ANAPC2 MTHFD2L PLEC HSPA5 HSP90AB1 CACNB2 BIN1 RAP1GDS1 LCORL POLR2A ECE1 OSBP RAB3GAP1 CDK5RAP3 ASF1B FAM53B GREB1 SNAP25 PBX2 MAB21L1 DKK3 HELLS | 3.09e-07 | 1006 | 267 | 25 | 15226823 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MATR3 FYCO1 RYR1 FAF2 CLTC AHCY PLEC HSPA5 DYNC1H1 HSP90AB1 CACNB2 SYNE1 POLR2A HUWE1 ECPAS ARHGDIA IARS2 THOP1 AKAP9 EIF3A XRCC6 AHNAK2 | 3.53e-07 | 807 | 267 | 22 | 30575818 |
| Pubmed | ACTR5 MATR3 BCR TRRAP UCHL5 TADA3 HSPA5 HSP90AB1 POLR2A ECPAS HEXIM2 POLR3C MOB1A HCFC1 HELLS | 4.23e-07 | 390 | 267 | 15 | 17643375 | |
| Pubmed | CAAP1 KCMF1 MED14 FYCO1 FAF2 SVIL CLTC PYCR1 TIMELESS PLEC HSPA5 RAP1GDS1 GMCL1 ARHGDIA CDK5RAP3 AKAP9 XRCC6 | 4.38e-07 | 503 | 267 | 17 | 36217030 | |
| Pubmed | 4.47e-07 | 3 | 267 | 3 | 29054927 | ||
| Pubmed | TTC39B GLYCTK MED14 BCR TRRAP TIAM2 MMP24 UCHL5 PYCR1 DYNC1H1 KIF2C EP400 SYNE1 POLR2A SPTLC1 APOB ECPAS ECE1 IFIT1 CREBBP XRCC6 | 4.66e-07 | 754 | 267 | 21 | 35906200 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 METTL3 MATR3 BMS1 SRPK1 ARHGAP11A LRCH1 CEP170 WDR3 SVIL CLTC DDX54 AHCY CRYBG1 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 RBBP6 OAT IFI16 IARS2 GTF3C1 ANKRD17 EIF3A SCRIB XRCC6 | 5.28e-07 | 1257 | 267 | 28 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MCMBP MATR3 WDR3 FAF2 PMPCA UCHL5 NAE1 CLTC AHCY PYCR1 GMDS BRAT1 HSPA5 DYNC1H1 HSP90AB1 POLR2A SPTLC1 OAT HUWE1 MORC4 WDR26 IARS2 GTF3C1 SCRIB CPSF3 HCFC1 XRCC6 HELLS | 5.28e-07 | 1257 | 267 | 28 | 37317656 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | CAAP1 SPAST HGH1 FAF2 PMPCA UCHL5 ZPR1 NAE1 TADA3 HSPA5 DYNC1LI2 HSP90AB1 RAP1GDS1 OAT POLR3C SCRIB HCFC1 XRCC6 SCAI SNX5 | 6.50e-07 | 704 | 267 | 20 | 32994395 |
| Pubmed | 6.88e-07 | 10 | 267 | 4 | 15808510 | ||
| Pubmed | METTL3 MAP1B KCMF1 RSF1 MED14 ARHGAP11A CEP170 KIF2C EP400 POLR2A HUWE1 CHMP4B CREBBP ASF1B SCRIB CPSF3 XRCC6 PCM1 HELLS | 7.29e-07 | 645 | 267 | 19 | 25281560 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.38e-07 | 167 | 267 | 10 | 20362541 | |
| Pubmed | SRPK1 CEP170 SVIL CLTC HSPA5 DYNC1H1 KLC1 HSP90AB1 FRMD6 PARD3 FGD6 CPSF3 | 7.63e-07 | 255 | 267 | 12 | 15324660 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | MAP1B MATR3 BMS1 CLTC AHCY GMDS HSPA5 DYNC1H1 HSP90AB1 OAT HUWE1 WDR26 | 7.96e-07 | 256 | 267 | 12 | 32698014 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | BCR TRRAP DYNC1H1 EP400 POLR2A SPTLC1 OAT HUWE1 GTF3C1 XRCC6 HELLS | 8.15e-07 | 211 | 267 | 11 | 17314511 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MCMBP MAP1B BMS1 CEP170 FAF2 NAE1 CLTC AHCY PYCR1 HSPA5 KIF2C HSP90AB1 RAP1GDS1 APEH HUWE1 ECPAS CHMP4B IFIT1 IARS2 CDK5RAP3 ATP6V0D1 SMARCA2 ANKRD17 EIF3A SCRIB CPSF3 HCFC1 XRCC6 AHNAK2 | 8.77e-07 | 1367 | 267 | 29 | 32687490 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MAP1B MATR3 CEP170 UCHL5 NAE1 SVIL CLTC AHCY PYCR1 PLEC HSPA5 DYNC1H1 KLC1 DYNC1LI2 HSP90AB1 HUWE1 MORC4 ECPAS WDR26 ARHGDIA GTF3C1 ANKRD17 EIF3A HCFC1 XRCC6 SNX5 | 1.03e-06 | 1149 | 267 | 26 | 35446349 |
| Pubmed | MAP1B FAF2 SVIL CLTC PLEC HSPA5 DYNC1H1 HSP90AB1 CHMP4B RAB3GAP1 IARS2 EIF3A AHNAK2 | 1.04e-06 | 312 | 267 | 13 | 37120454 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MCMBP MAP1B BMS1 BCR TRRAP COPS7A WDR3 FAF2 PMPCA UCHL5 NAE1 PLEC TADA3 USP13 OTUD5 OAT HUWE1 WDR26 SIRT1 SMARCA2 ANKRD17 EIF3A SCRIB HCFC1 | 1.08e-06 | 1005 | 267 | 24 | 19615732 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | MAP1B POGZ TRRAP PLEC HSPA5 FRAS1 POLR2A SIRT1 GTF3C1 XRCC6 HELLS | 1.17e-06 | 219 | 267 | 11 | 31353912 |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.32e-06 | 178 | 267 | 10 | 27637333 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NCOA3 CAAP1 MATR3 WDR3 SVIL CLTC DDX54 GFPT2 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 RBBP6 SYNE1 APOB CHMP4B IFI16 ASF1B EIF3A SCRIB CPSF3 XRCC6 | 1.43e-06 | 949 | 267 | 23 | 36574265 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MAP1B MATR3 TRRAP CEP170 WDR3 SVIL CLTC DDX54 AHCY PLEC HSPA5 DYNC1H1 HSP90AB1 EP400 SYNE1 POLR2A HUWE1 ARHGDIA GTF3C1 EIF3A SCRIB XRCC6 PCM1 HELLS | 1.50e-06 | 1024 | 267 | 24 | 24711643 |
| Pubmed | MATR3 TRRAP CLTC PLEC HSPA5 DYNC1H1 HSP90AB1 USP13 KDM5A WDR26 GTF3C1 HELLS | 1.50e-06 | 272 | 267 | 12 | 31010829 | |
| Pubmed | MATR3 SRPK1 CEP170 SVIL CLTC PLEC HSPA5 HSP90AB1 RBBP6 EIF3A SCRIB CPSF3 | 1.62e-06 | 274 | 267 | 12 | 34244482 | |
| Pubmed | 1.66e-06 | 142 | 267 | 9 | 30217970 | ||
| Pubmed | CAAP1 METTL3 ACTR5 BMS1 MED14 ZMYM2 SRPK1 TRRAP SEMA4C WDR3 TOLLIP CRYBG1 TADA3 KIF2C EP400 KDM5A RBBP6 SYNE1 POLR2A CHMP4B CELSR1 CDK5RAP3 ATP6V0D1 FARP1 LTN1 SMARCA2 ANKRD17 EIF3A PRPF38A PARD3 | 1.79e-06 | 1497 | 267 | 30 | 31527615 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | METTL3 MAP1B TMOD2 TRRAP AHCY TOLLIP HSPA5 DYNC1H1 HSP90AB1 BIN1 SASH1 GRIK5 HUWE1 ATP6V0D1 ERC2 EIF3A SNAP25 PARD3 | 1.80e-06 | 621 | 267 | 18 | 22794259 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | CEP170 FSIP2 FAF2 CLTC AHCY TOLLIP DYNC1H1 HSP90AB1 RAP1GDS1 CHMP4B RAB3GAP1 ATP6V0D1 FARP1 SMARCA2 EIF3A SNAP25 SNX5 | 1.80e-06 | 558 | 267 | 17 | 35063084 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MED14 FYCO1 TRRAP CEP170 WDR3 CLTC DDX54 GFPT2 EP400 POLR2A HUWE1 GTF3C1 SMARCA2 ANKRD17 SCRIB | 1.90e-06 | 440 | 267 | 15 | 34244565 |
| Pubmed | SVIL NFKBIA CLTC PLEC DYNC1H1 HSP90AB1 HUWE1 CREBBP IGFBP4 FARP1 SCRIB PCM1 AHNAK2 | 2.07e-06 | 332 | 267 | 13 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ZMYM2 CLTC PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 POLR2A HUWE1 GTF3C1 HCFC1 AHNAK2 | 2.07e-06 | 332 | 267 | 13 | 32786267 |
| Pubmed | 2.21e-06 | 147 | 267 | 9 | 16959763 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | MED14 ZMYM2 POGZ TRRAP WDR3 DDX54 EP400 RBBP6 POLR2A ECPAS GTF3C1 GREB1 HCFC1 | 2.77e-06 | 341 | 267 | 13 | 32971831 |
| Pubmed | ZMYM2 TMOD2 ARHGAP11A BCR LRCH1 TIAM2 CEP170 PYCR1 PLEC BIN1 RASGRF2 SPTLC1 HUWE1 ECPAS PREX2 ARHGAP4 FARP1 DNM3 PRPF38A SCRIB FGD6 CPSF3 | 2.82e-06 | 916 | 267 | 22 | 32203420 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ACTR5 MATR3 ZMYM2 POGZ ARHGAP11A TRRAP WDR3 UCHL5 ANAPC2 DDX54 TADA3 HSPA5 KIF2C TFEB EP400 KDM5A RBBP6 POLR2A POT1 IFI16 ZNF106 GTF3C1 PRPF38A CPSF3 HCFC1 XRCC6 HELLS | 2.91e-06 | 1294 | 267 | 27 | 30804502 |
| Pubmed | MAP1B MATR3 CEP170 FSIP2 UCHL5 ZPR1 KLC1 DYNC1LI2 RBBP6 APEH ARHGDIA SCRIB HCFC1 SNX5 | 3.01e-06 | 399 | 267 | 14 | 35987950 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | MATR3 FAF2 CLTC AHCY HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 USP24 HUWE1 FAM53B SCRIB XRCC6 | 3.05e-06 | 344 | 267 | 13 | 36282215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | METTL3 VPS33B UCHL5 ANAPC2 PLEC HSPA5 DYNC1H1 DYNC1LI2 KIF2C HSP90AB1 USP24 HUWE1 SMARCA2 SCRIB CPSF3 XRCC6 HELLS | 3.17e-06 | 582 | 267 | 17 | 20467437 |
| Interaction | EP300 interactions | NCOA3 MCMBP HGH1 MATR3 RSF1 SRPK1 FYCO1 SYNC RXRA MAP3K5 FAF2 NFKBIA ANAPC2 CLTC DDX54 AHCY NFYA GFPT2 TADA3 HSPA5 KLC1 FRAS1 RBBP6 POLR2A USP24 PPP1R13B PATL1 ECPAS IFI16 IFIT1 CREBBP SIRT1 POLR3C ARHGDIA ZNF106 OSBP GTF3C1 SMARCA2 DNM3 TNK2 SCRIB CPSF3 XRCC6 HELLS | 5.35e-08 | 1401 | 264 | 44 | int:EP300 |
| Interaction | YWHAZ interactions | PNMA1 MATR3 RSF1 SMC5 BCR LRCH1 MAP3K5 CEP170 FSIP2 UCHL5 SVIL CLTC KCNMA1 MAP3K11 PLEC HSPA5 DYNC1H1 KLC1 HSP90AB1 TFEB BIN1 SASH1 RASGRF2 HUWE1 SIK3 IFI16 THAP9 MADD AKAP9 FRMD6 ANKRD17 CDK5RAP2 TNK2 CD74 FAM53B EIF3A SCRIB PARD3 FGD6 XRCC6 PCM1 | 2.15e-07 | 1319 | 264 | 41 | int:YWHAZ |
| Interaction | CSNK2B interactions | SPAST ACTR5 BMS1 POGZ SMC5 BCR RXRA COPS7A CEP170 UCHL5 NFKBIA DDX54 DYNC1H1 KIF2C EP400 POLR2A POT1 CHMP4B IFI16 CREBBP SIRT1 HEXIM2 MADD ZNF106 PRPF38A HCFC1 | 2.27e-07 | 625 | 264 | 26 | int:CSNK2B |
| Interaction | DYRK1A interactions | MAP1B TMOD2 SRPK1 LRCH1 MAP3K5 NELL1 ANAPC2 CLTC AHCY TOLLIP TIMELESS USP13 HUWE1 WDR26 CREBBP SIRT1 DNM3 CDK5RAP2 FAM53B LTBP3 SCRIB DKK3 XRCC6 AHNAK2 | 3.08e-07 | 552 | 264 | 24 | int:DYRK1A |
| Interaction | CEBPA interactions | NCOA3 SPAST MATR3 MED14 ZMYM2 POGZ TRRAP CEP170 NAE1 CLTC DDX54 AHCY NFYA TADA3 HSPA5 DYNC1H1 KIF2C SRA1 EP400 LCORL POLR2A ZNF507 APEH ECPAS CHMP4B IFI16 CREBBP GMNN SIRT1 ZNF3 ARHGDIA AKAP9 GTF3C1 SMARCA2 ELF1 HCFC1 XRCC6 PCM1 HELLS | 3.65e-07 | 1245 | 264 | 39 | int:CEBPA |
| Interaction | YWHAG interactions | MCMBP SPAST MATR3 SRPK1 BCR TRRAP MAP3K5 CEP170 SVIL CLTC KCNMA1 DYNC1H1 KLC1 KIF2C HSP90AB1 TFEB SASH1 MCFD2 CARMIL1 POT1 USP24 HUWE1 SIK3 IFI16 DNAH7 ZNF106 IARS2 AKAP9 FRMD6 ANKRD17 TNK2 FAM53B SCRIB PARD3 FGD6 CPSF3 PCM1 DOP1A AHNAK2 | 3.88e-07 | 1248 | 264 | 39 | int:YWHAG |
| Interaction | YWHAH interactions | NCOA3 MCMBP SPAST MATR3 BCR MAP3K5 CEP170 SVIL KCNMA1 PLEC KLC1 KIF2C HSP90AB1 TFEB SASH1 KDM5A CARMIL1 HUWE1 SIK3 WDR26 CREBBP DNAH7 MADD ZNF106 IARS2 AKAP9 FRMD6 MOB1A ANKRD17 FAM53B SCRIB PARD3 FGD6 PCM1 DOP1A AHNAK2 | 4.04e-07 | 1102 | 264 | 36 | int:YWHAH |
| Interaction | FMR1 interactions | NCOA3 SPAST MAP1B MATR3 TRRAP CEP170 KCNMA1 DYNC1H1 KLC1 CACNB2 BIN1 SRA1 KDM5A RBBP6 SIK3 IFI16 AKAP9 ANKRD17 CDK5RAP2 SCRIB LTK PARD3 PCM1 | 6.88e-07 | 536 | 264 | 23 | int:FMR1 |
| Interaction | TNIK interactions | MATR3 ZMYM2 BCR TIAM2 CEP170 KCNMA1 ARC TOLLIP DYNC1H1 DYNC1LI2 KIF2C BIN1 SYNE1 PPP1R13B HUWE1 GRM5 AKAP9 ERC2 PCM1 | 7.34e-07 | 381 | 264 | 19 | int:TNIK |
| Interaction | HOXB7 interactions | 8.82e-07 | 26 | 264 | 6 | int:HOXB7 | |
| Interaction | DYNLL1 interactions | METTL3 MAP1B ZMYM2 POGZ SMC5 BCR COPS7A NFKBIA HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 SPTLC1 CHMP4B IFI16 AKAP9 ASF1B DNM3 CDK5RAP2 FAM53B PARD3 PCM1 | 1.11e-06 | 510 | 264 | 22 | int:DYNLL1 |
| Interaction | WEE2-AS1 interactions | DOHH DNAAF5 TIMELESS ASPSCR1 PLEC BRAT1 HSP90AB1 IFIT1 GTF3C1 MOB1A EIF3A XRCC6 | 1.68e-06 | 163 | 264 | 12 | int:WEE2-AS1 |
| Interaction | NR3C1 interactions | NCOA3 RSF1 MED14 ZMYM2 POGZ RYR1 RYR2 FAF2 SVIL DDX54 PYCR1 GFPT2 HSPA5 HSP90AB1 SRA1 KDM5A POT1 USP24 SIK3 MORC4 IFIT1 CREBBP DNAH7 DYDC1 OSBP RAB3GAP1 SMARCA2 ANKRD17 CDK5RAP2 PBX1 AHNAK2 HELLS | 1.68e-06 | 974 | 264 | 32 | int:NR3C1 |
| Interaction | SIRT7 interactions | MAP1B RSF1 BMS1 SRPK1 POGZ TRRAP CEP170 WDR3 CLTC DDX54 PLEC DYNC1H1 POLR2A USP24 OAT HUWE1 ECPAS SIRT1 ARHGDIA IARS2 GTF3C1 SMARCA2 ANKRD17 CPSF3 HCFC1 XRCC6 PCM1 | 1.86e-06 | 744 | 264 | 27 | int:SIRT7 |
| Interaction | CIT interactions | CLGN MATR3 RSF1 BMS1 TMOD2 SRPK1 POGZ TRRAP MAP3K5 CEP170 WDR3 FAF2 SVIL CLTC PYCR1 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 RBBP6 SYNE1 POLR2A APOB ECPAS CHMP4B IFI16 POLR3C AKAP9 SMARCA2 CDK5RAP2 ELF1 MYOM2 EIF3A PRPF38A SCRIB PARD3 HCFC1 XRCC6 AHNAK2 | 2.46e-06 | 1450 | 264 | 41 | int:CIT |
| Interaction | SMAD2 interactions | NCOA3 METTL3 CYP11A1 ZMYM2 RXRA UCHL5 ANAPC2 LDLRAD4 DYNC1H1 RANBP6 HUWE1 SIK3 CREBBP TGFBR2 PBX1 PARD3 HCFC1 XRCC6 | 3.59e-06 | 385 | 264 | 18 | int:SMAD2 |
| Interaction | VCP interactions | CAAP1 CLUAP1 METTL3 MCMBP CLGN SPAST MATR3 KCMF1 RSU1 RXRA COPS7A DNAAF5 FAF2 UCHL5 NFKBIA CLTC DDX54 AHCY KCNMA1 ASPSCR1 PLEC BRAT1 HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 USP13 POLR2A APOB HUWE1 CHMP4B POLR3C TGFBR2 ARHGDIA RAB3GAP1 GTF3C1 DNM3 EIF3A XRCC6 HELLS | 4.69e-06 | 1435 | 264 | 40 | int:VCP |
| Interaction | HOXA9 interactions | 4.72e-06 | 34 | 264 | 6 | int:HOXA9 | |
| Interaction | SFN interactions | MAP1B MATR3 ARHGAP11A BCR MAP3K5 CEP170 SVIL CLTC PLEC HSPA5 KLC1 SASH1 CARMIL1 SIK3 WDR26 OSBP AKAP9 FRMD6 ANKRD17 FAM53B SCRIB PARD3 FGD6 DOP1A AHNAK2 | 4.94e-06 | 692 | 264 | 25 | int:SFN |
| Interaction | TBP interactions | NCOA3 RXRA NFYA TADA3 KDM5A POLR2A HUWE1 AAGAB CREBBP GMNN POLR3C SMARCA2 ELF1 CPSF3 | 6.73e-06 | 253 | 264 | 14 | int:TBP |
| Interaction | MYH9 interactions | NCOA3 MAP1B ARHGAP11A SMC5 TRRAP RXRA COPS7A WDR3 SVIL CLTC PLEC HSPA5 KLC1 HSP90AB1 CARMIL1 OAT APOB HUWE1 CHMP4B CREBBP IARS2 LTN1 TNK2 MYOM2 EIF3A XRCC6 | 7.28e-06 | 754 | 264 | 26 | int:MYH9 |
| Interaction | GTF2I interactions | METTL3 MCMBP MATR3 ZMYM2 SMC5 CEP170 UCHL5 NAE1 NFKBIA CLTC AHCY DYNC1H1 HSP90AB1 POLR2A CHMP4B CD74 XRCC6 | 9.38e-06 | 373 | 264 | 17 | int:GTF2I |
| Interaction | YWHAB interactions | MATR3 BCR TRRAP MAP3K5 CEP170 VPS33B SVIL CLTC KCNMA1 HSPA5 DYNC1H1 KLC1 HSP90AB1 TFEB BIN1 SASH1 OAT SIK3 CHMP4B ZNF106 OSBP AKAP9 FRMD6 ANKRD17 CD74 FAM53B SCRIB PARD3 FGD6 PCM1 AHNAK2 | 1.05e-05 | 1014 | 264 | 31 | int:YWHAB |
| Interaction | WWTR1 interactions | MAP1B POGZ TRRAP CEP170 CLTC HSPA5 KLC1 EP400 POLR2A USP24 PPP1R13B CREBBP TGFBR2 GTF3C1 SCRIB PARD3 HCFC1 PCM1 | 1.26e-05 | 422 | 264 | 18 | int:WWTR1 |
| Interaction | GAPDH interactions | METTL3 SPAST MAP1B SMC5 RYR1 MAP3K5 CEP170 WDR3 SVIL CLTC AHCY KCNMA1 ASPSCR1 HSPA5 HSP90AB1 RAP1GDS1 SRA1 MYH7B POT1 HUWE1 SIRT1 SMARCA2 SNAP25 HCFC1 | 1.31e-05 | 686 | 264 | 24 | int:GAPDH |
| Interaction | MCRS1 interactions | ACTR5 C8orf34 MAP3K5 COPS7A CCDC13 UCHL5 TADA3 SASH1 PPP1R13B ELF1 PBX2 HCFC1 PCM1 | 1.44e-05 | 235 | 264 | 13 | int:MCRS1 |
| Interaction | PSMD11 interactions | MAP1B KCMF1 VPS33B UCHL5 AHCY KCNMA1 TOLLIP HSPA5 DYNC1H1 KLC1 HSP90AB1 MCFD2 HUWE1 ECPAS TGFBR2 ASF1B | 1.84e-05 | 353 | 264 | 16 | int:PSMD11 |
| Interaction | YWHAE interactions | MAP1B MATR3 SMC5 BCR LRCH1 MAP3K5 CEP170 CCNYL1 ZPR1 SVIL CLTC DDX54 KCNMA1 DYNC1H1 KLC1 HSP90AB1 TFEB RAP1GDS1 SASH1 MCFD2 POT1 HUWE1 SIK3 ZNF106 IARS2 AKAP9 FRMD6 ANKRD17 ERC2 CD74 FAM53B EIF3A PARD3 FGD6 PCM1 | 1.99e-05 | 1256 | 264 | 35 | int:YWHAE |
| Interaction | HSPB1 interactions | KRT72 CLUAP1 MAP1B MATR3 KCMF1 SRPK1 TRRAP CLCN3 UCHL5 NFKBIA AHCY HSPA5 DYNC1H1 KLC1 HSP90AB1 HUWE1 ECPAS CHMP4B CREBBP ARHGDIA IARS2 CDK5RAP3 SMARCA2 CPSF3 | 2.19e-05 | 708 | 264 | 24 | int:HSPB1 |
| Interaction | EIF4B interactions | DOHH METTL3 MCMBP USP9Y SMC5 TRRAP AHCY TOLLIP HSPA5 DYNC1H1 KLC1 DYNC1LI2 POT1 HUWE1 IFI16 OSBP EIF3A | 2.45e-05 | 402 | 264 | 17 | int:EIF4B |
| Interaction | NUP43 interactions | SPAST ACTR5 RSF1 BMS1 ZMYM2 POGZ RYR2 HELB WDR3 FSIP2 TIMELESS TADA3 DNAH9 HSP90AB1 EP400 KDM5A RBBP6 IFI16 ASF1B ELF1 HCFC1 AHNAK2 | 2.77e-05 | 625 | 264 | 22 | int:NUP43 |
| Interaction | YWHAQ interactions | NCOA3 MATR3 SMC5 BCR MAP3K5 CEP170 SVIL CLTC AHCY KCNMA1 PLEC DYNC1H1 KLC1 HSP90AB1 TFEB SASH1 MCFD2 SIK3 CHMP4B IFI16 DNAH7 ZNF106 IARS2 FRMD6 ANKRD17 CD74 FAM53B SCRIB PARD3 FGD6 PCM1 DOP1A | 2.78e-05 | 1118 | 264 | 32 | int:YWHAQ |
| Interaction | CAPZA1 interactions | MCMBP TRRAP RXRA UCHL5 NAE1 SVIL CLTC HSPA5 DYNC1H1 KLC1 MCFD2 CARMIL1 HUWE1 CHMP4B WASH3P ASF1B | 2.86e-05 | 366 | 264 | 16 | int:CAPZA1 |
| Interaction | EED interactions | MAP1B MATR3 PEG3 MED14 ZMYM2 POGZ SMC5 TRRAP WDR3 SVIL CLTC DDX54 KCNMA1 PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 KDM5A RBBP6 POLR2A HUWE1 SIRT1 ARHGDIA RAB3GAP1 THOP1 ATP6V0D1 GTF3C1 LTN1 SMARCA2 EIF3A PRPF38A CPSF3 HCFC1 XRCC6 PCM1 HELLS | 3.06e-05 | 1445 | 264 | 38 | int:EED |
| Interaction | ETS1 interactions | 3.12e-05 | 121 | 264 | 9 | int:ETS1 | |
| Interaction | NUDT21 interactions | METTL3 KCMF1 SRPK1 ARHGAP11A SMC5 TRRAP PYCR1 TOLLIP RBBP6 POLR2A HUWE1 SIRT1 EIF3A PRPF38A CPSF3 XRCC6 | 3.16e-05 | 369 | 264 | 16 | int:NUDT21 |
| Interaction | PSMD12 interactions | MAP1B KCMF1 COPS7A VPS33B UCHL5 AHCY HSPA5 KLC1 HSP90AB1 MCFD2 HUWE1 ECPAS IFI16 ASF1B XRCC6 | 3.37e-05 | 331 | 264 | 15 | int:PSMD12 |
| Interaction | KAT2B interactions | NCOA3 PNMA1 RSF1 TRRAP NFYA TADA3 POLR2A CREBBP SIRT1 ARHGDIA SMARCA2 ELF1 XRCC6 | 3.54e-05 | 256 | 264 | 13 | int:KAT2B |
| Interaction | MCM7 interactions | MCMBP PNMA1 MAP1B SRPK1 POGZ C8orf34 NFKBIA TIMELESS HSP90AB1 POLR2A RANBP6 HUWE1 SIK3 IFI16 AK8 ASF1B HELLS | 3.55e-05 | 414 | 264 | 17 | int:MCM7 |
| Interaction | SUMO2 interactions | ZMYM2 POGZ SMC5 NFKBIA ANAPC2 CLTC ARC PLEC HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 POLR2A HUWE1 SIRT1 GTF3C1 LTK HCFC1 XRCC6 AHNAK2 | 3.70e-05 | 591 | 264 | 21 | int:SUMO2 |
| Interaction | ACTB interactions | METTL3 PNMA1 MAP1B ACTR5 MATR3 TMOD2 SMC5 FSIP2 UCHL5 SVIL AHCY KCNMA1 PLEC TADA3 HSPA5 DYNC1H1 KLC1 HSP90AB1 SRA1 EP400 COG7 POLR2A POT1 WASHC1 IFI16 IFIT1 CREBBP WASH3P SMARCA2 SCRIB PCM1 | 3.74e-05 | 1083 | 264 | 31 | int:ACTB |
| Interaction | TOP3B interactions | SDSL PDE4A ANKS6 KCMF1 MED14 FYCO1 BCR TRRAP RYR1 TIAM2 MAP3K5 SVIL ARC MAP3K11 PLEC CIAO2A BRAT1 HSPA5 DYNC1H1 TFEB FRAS1 EP400 POLR2A APEH APOB PATL1 HUWE1 ECE1 MADD CELSR1 ZNF341 ANKRD17 TNK2 LTBP3 LTK HCFC1 XRCC6 AHNAK2 | 4.43e-05 | 1470 | 264 | 38 | int:TOP3B |
| Interaction | VDR interactions | 4.57e-05 | 127 | 264 | 9 | int:VDR | |
| Interaction | DDB1 interactions | METTL3 MAP1B ACTR5 MATR3 RSF1 MED14 COPS7A WDR3 FAF2 KCNMA1 HSPA5 DYNC1H1 KLC1 POLR2A HUWE1 CHMP4B WDR26 CREBBP SIRT1 FARP1 SMARCA2 EIF3A HELLS | 4.94e-05 | 697 | 264 | 23 | int:DDB1 |
| Interaction | BRCA2 interactions | RSF1 SMC5 TRRAP UCHL5 ANAPC2 TIMELESS PLEC DNAH9 DYNC1H1 DYNC1LI2 HSP90AB1 POLR2A HUWE1 CHMP4B DYDC1 XRCC6 | 5.08e-05 | 384 | 264 | 16 | int:BRCA2 |
| Interaction | PSMC4 interactions | METTL3 SPAST MAP1B MAP3K5 UCHL5 ANAPC2 TOLLIP HERC3 KLC1 MCFD2 HUWE1 ECPAS IFI16 TGFBR2 RAB3GAP1 | 5.23e-05 | 344 | 264 | 15 | int:PSMC4 |
| Interaction | FBXO32 interactions | METTL3 MCMBP SYNC WDR3 FAF2 PMPCA UCHL5 NAE1 NFKBIA PLEC POLR2A SPTLC1 ARHGDIA THOP1 GTF3C1 HELLS | 5.40e-05 | 386 | 264 | 16 | int:FBXO32 |
| Interaction | TNK2 interactions | MAP1B MATR3 CEP170 SVIL CLTC KCNMA1 SH2D7 HSP90AB1 BIN1 TNK2 LTK | 5.52e-05 | 195 | 264 | 11 | int:TNK2 |
| Interaction | PSMD13 interactions | METTL3 MCMBP MAP1B KCMF1 SRPK1 UCHL5 AHCY DYNC1H1 KLC1 HUWE1 ECPAS IFI16 TGFBR2 ASF1B | 5.56e-05 | 306 | 264 | 14 | int:PSMD13 |
| Interaction | PSMD3 interactions | MAP1B KCMF1 TRRAP VPS33B UCHL5 NFKBIA HSPA5 DYNC1H1 KLC1 MCFD2 HUWE1 ECPAS IFI16 ATP6V0D1 CD74 XRCC6 | 6.10e-05 | 390 | 264 | 16 | int:PSMD3 |
| Interaction | CDC5L interactions | MATR3 BMS1 SRPK1 SMC5 VPS33B UCHL5 ANAPC2 PLEC HSPA5 DYNC1H1 DYNC1LI2 KIF2C HSP90AB1 RBBP6 SYNE1 POLR2A USP24 PPP1R13B HUWE1 IFI16 TGFBR2 AKAP9 SMARCA2 SCRIB CPSF3 HELLS | 6.19e-05 | 855 | 264 | 26 | int:CDC5L |
| Interaction | ARRDC2 interactions | 7.28e-05 | 54 | 264 | 6 | int:ARRDC2 | |
| Interaction | MECP2 interactions | CAAP1 MAP1B MATR3 BMS1 MED14 ZMYM2 POGZ USP9Y SMC5 LRCH1 TRRAP CEP170 CLTC DDX54 PLEC HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 EP400 KDM5A RBBP6 SYNE1 POLR2A SIK3 CHMP4B SIRT1 GTF3C1 FARP1 SMARCA2 DNM3 PRPF38A CPSF3 XRCC6 | 7.64e-05 | 1287 | 264 | 34 | int:MECP2 |
| Interaction | E2F3 interactions | 7.93e-05 | 79 | 264 | 7 | int:E2F3 | |
| Interaction | NPTN interactions | DNAAF5 ANAPC2 PYCR1 BRAT1 COG7 USP24 HUWE1 ECPAS LTN1 SNAP25 DOP1A SCAI SNX5 | 8.22e-05 | 278 | 264 | 13 | int:NPTN |
| Interaction | UFD1 interactions | TIAM2 FAF2 VPS33B UCHL5 NFKBIA ANAPC2 ASPSCR1 USP13 HUWE1 TGFBR2 | 8.49e-05 | 170 | 264 | 10 | int:UFD1 |
| Interaction | EGLN3 interactions | MCMBP HGH1 KCMF1 BCR LRCH1 MAP3K5 CEP170 FAF2 UCHL5 NAE1 NFKBIA GMDS DYNC1H1 KIF2C OTUD5 POLR2A USP24 SPTLC1 ZNF507 PATL1 SIK3 ECPAS WDR26 CREBBP SIRT1 ZNF106 RAB3GAP1 GTF3C1 ANKRD17 CDK5RAP2 SCRIB PARD3 HCFC1 PCM1 | 8.75e-05 | 1296 | 264 | 34 | int:EGLN3 |
| Interaction | SIRT6 interactions | PI4K2B METTL3 MATR3 MED14 FYCO1 TRRAP CEP170 WDR3 CLTC DDX54 GFPT2 EP400 POLR2A HUWE1 CREBBP CELSR1 GTF3C1 SMARCA2 ANKRD17 SCRIB XRCC6 | 8.78e-05 | 628 | 264 | 21 | int:SIRT6 |
| Interaction | TRIM28 interactions | METTL3 MCMBP MAP1B MATR3 RSF1 MED14 SMC5 TRRAP FAF2 VPS33B CLTC AHCY TIMELESS DYNC1H1 KLC1 DYNC1LI2 POLR2A SPTLC1 GRIK5 HUWE1 IFI16 WDR26 CREBBP SIRT1 RAB3GAP1 IARS2 CDK5RAP3 GTF3C1 ASF1B LTN1 SMARCA2 ANKRD17 TNK2 PRPF38A SCRIB HCFC1 XRCC6 | 1.03e-04 | 1474 | 264 | 37 | int:TRIM28 |
| Interaction | HNRNPD interactions | NCOA3 METTL3 MAP1B MATR3 MED14 SMC5 TRRAP PYCR1 GMDS HSPA5 DYNC1H1 SLC27A5 HSP90AB1 USP13 SRA1 COG7 POLR2A USP24 ECPAS IFI16 XRCC6 | 1.09e-04 | 638 | 264 | 21 | int:HNRNPD |
| Interaction | YY1 interactions | ACTR5 ZMYM2 POGZ SMC5 TRRAP SEMA4C UCHL5 TADA3 HSPA5 EP400 CREBBP GMCL1 GTF3C1 ELF1 PRPF38A HCFC1 XRCC6 | 1.10e-04 | 454 | 264 | 17 | int:YY1 |
| Interaction | ECT2 interactions | METTL3 MATR3 TMOD2 SRPK1 USP9Y TRRAP CEP170 SVIL CLTC PLEC DNAH9 DYNC1H1 HSP90AB1 SPTLC1 OAT SIRT1 MADD ATP6V0D1 FARP1 MYO1F EIF3A PRPF38A SCRIB PARD3 XRCC6 AHNAK2 | 1.12e-04 | 887 | 264 | 26 | int:ECT2 |
| Interaction | TEX9 interactions | 1.15e-04 | 37 | 264 | 5 | int:TEX9 | |
| Interaction | CACYBP interactions | CLUAP1 TSSK2 TRRAP ANAPC2 CLTC HSP90AB1 USP13 OTUD5 PATL1 HUWE1 SIK3 IFI16 XRCC6 | 1.17e-04 | 288 | 264 | 13 | int:CACYBP |
| Interaction | PARP1 interactions | KCMF1 RSF1 BMS1 MED14 POGZ SMC5 TRRAP RXRA CEP170 WDR3 SVIL DDX54 NFYA TIMELESS BRAT1 HSPA5 HSP90AB1 RAP1GDS1 EP400 OTUD5 POLR2A RANBP6 HUWE1 IFI16 CREBBP SIRT1 ZNF106 GTF3C1 SMARCA2 CDK5RAP2 SCRIB LTK XRCC6 HELLS | 1.17e-04 | 1316 | 264 | 34 | int:PARP1 |
| Interaction | KDM1A interactions | NCOA3 ZMYM2 FYCO1 POGZ BCR TRRAP UCHL5 PLEC TADA3 PHF21B KLC1 EP400 KDM5A LCORL POLR2A USP24 ZNF507 HUWE1 MORC4 ECPAS WDR26 AKAP9 IGFBP4 GTF3C1 SMARCA2 ANKRD17 PCM1 | 1.17e-04 | 941 | 264 | 27 | int:KDM1A |
| Interaction | MDC1 interactions | POGZ SMC5 TRRAP ANAPC2 PYCR1 USP13 POLR2A POT1 IFI16 WDR26 CREBBP ZNF106 GTF3C1 CPSF3 XRCC6 SCAI | 1.22e-04 | 414 | 264 | 16 | int:MDC1 |
| Interaction | SERBP1 interactions | EFCAB5 CAAP1 MCMBP MAP1B HGH1 NUTM2A SMC5 TRRAP DNAAF5 FAF2 PMPCA UCHL5 ZPR1 NAE1 CLTC AHCY BRAT1 HSPA5 DYNC1H1 HSP90AB1 RAP1GDS1 MYH7B USP24 SPTLC1 OAT HUWE1 ECPAS CHMP4B IFI16 SIRT1 IARS2 DNM3 ANKRD17 EIF3A XRCC6 SNX5 | 1.26e-04 | 1432 | 264 | 36 | int:SERBP1 |
| Interaction | CCT8 interactions | PI4K2B METTL3 MCMBP SPAST MAP1B SMC5 PTPRR AHCY GFPT2 HSPA5 KLC1 MYH7B SYNE1 HUWE1 SIK3 IFI16 TNK2 EIF3A XRCC6 | 1.26e-04 | 550 | 264 | 19 | int:CCT8 |
| Interaction | FBXO38 interactions | 1.28e-04 | 145 | 264 | 9 | int:FBXO38 | |
| Interaction | CREBBP interactions | NCOA3 MAP1B ZMYM2 TRRAP RXRA MAP3K5 ANAPC2 NFYA PYCR1 HSP90AB1 POLR2A POT1 HUWE1 CREBBP ZNF106 CDK5RAP3 MOB1A SMARCA2 PBX1 XRCC6 | 1.32e-04 | 599 | 264 | 20 | int:CREBBP |
| Interaction | PARD6B interactions | 1.34e-04 | 146 | 264 | 9 | int:PARD6B | |
| Interaction | PAGE4 interactions | MAP1B MATR3 BMS1 CLTC AHCY GMDS HSPA5 DYNC1H1 HSP90AB1 OAT HUWE1 WDR26 | 1.35e-04 | 253 | 264 | 12 | int:PAGE4 |
| Interaction | MKI67 interactions | MAP1B ACTR5 SRPK1 SMC5 TRRAP WDR3 DDX54 TOLLIP FRAS1 EP400 ECPAS CHMP4B IFI16 ZNF106 CDK5RAP3 GTF3C1 SMARCA2 DNM3 SCRIB HCFC1 XRCC6 | 1.36e-04 | 648 | 264 | 21 | int:MKI67 |
| Interaction | STIP1 interactions | METTL3 TSSK2 WDR3 DNAAF5 FAF2 ANAPC2 CLTC KCNMA1 PYCR1 PLEC HSPA5 DYNC1H1 HSP90AB1 COG7 POLR2A POT1 USP24 HUWE1 SIK3 ECPAS WDR26 FARP1 MOB1A EIF3A SCRIB CPSF3 XRCC6 HELLS | 1.46e-04 | 1006 | 264 | 28 | int:STIP1 |
| Interaction | CCAR2 interactions | METTL3 PNMA1 MAP1B MATR3 CEP170 WDR3 CLTC PLEC HSP90AB1 OTUD5 USP24 IFI16 CREBBP SIRT1 | 1.54e-04 | 337 | 264 | 14 | int:CCAR2 |
| Interaction | MAPRE1 interactions | MAP1B COPS7A CEP170 SVIL CLTC PLEC HSPA5 DYNC1H1 DYNC1LI2 KIF2C HSP90AB1 PPP1R13B PATL1 CDK5RAP3 AKAP9 CDK5RAP2 EIF3A PCM1 | 1.60e-04 | 514 | 264 | 18 | int:MAPRE1 |
| Interaction | MAPT interactions | MAP1B SRPK1 USP9Y CEP170 FSIP2 FAF2 DGUOK CLTC AHCY TOLLIP HSPA5 DYNC1H1 HSP90AB1 TFEB BIN1 RAP1GDS1 MYH7B APEH ECPAS CHMP4B WDR26 CREBBP SIRT1 RAB3GAP1 ATP6V0D1 FARP1 SMARCA2 EIF3A SNAP25 SNX5 | 1.61e-04 | 1119 | 264 | 30 | int:MAPT |
| Interaction | DNAJC7 interactions | IFT140 METTL3 MCMBP TRRAP NAE1 SVIL ANAPC2 CLTC HSPA5 HSP90AB1 APEH HUWE1 TGFBR2 IARS2 CDK5RAP2 GREB1 | 1.65e-04 | 425 | 264 | 16 | int:DNAJC7 |
| Interaction | SH2D7 interactions | 1.71e-04 | 2 | 264 | 2 | int:SH2D7 | |
| Interaction | CCDC68 interactions | 1.75e-04 | 22 | 264 | 4 | int:CCDC68 | |
| Interaction | PRKACA interactions | RYR1 RYR2 CEP170 PTPRR CLTC AHCY GFPT2 DYNC1H1 HSP90AB1 CACNB2 HUWE1 SIK3 IFI16 THOP1 AKAP9 CDK5RAP2 SNAP25 PARD3 | 1.81e-04 | 519 | 264 | 18 | int:PRKACA |
| Interaction | ESRRB interactions | NCOA3 MED14 SYNC TRRAP HSPA5 HSP90AB1 TFEB EP400 KDM5A POLR2A HCFC1 XRCC6 | 1.87e-04 | 262 | 264 | 12 | int:ESRRB |
| Interaction | SNCA interactions | SPAST MAP1B KATNB1 TMOD2 FAF2 DGUOK SVIL CLTC HSPA5 DYNC1H1 KLC1 DYNC1LI2 BIN1 POLR2A USP24 ECPAS CHMP4B FARP1 SNAP25 SCRIB HCFC1 XRCC6 | 2.00e-04 | 716 | 264 | 22 | int:SNCA |
| Interaction | SLX4 interactions | MATR3 ZMYM2 POGZ ARHGAP11A SMC5 CLTC DDX54 AHCY HSPA5 DYNC1H1 KIF2C HSP90AB1 EP400 POLR2A CREBBP SIRT1 ZNF106 HCFC1 HELLS | 2.08e-04 | 572 | 264 | 19 | int:SLX4 |
| Interaction | CSNK2A2 interactions | CLUAP1 BCR TRRAP CEP170 CLTC DDX54 HSPA5 DYNC1LI2 KIF2C HSP90AB1 EP400 PATL1 HUWE1 IFI16 CREBBP SIRT1 HEXIM2 POLR3C ZNF106 GTF3C1 EIF3A AHNAK2 | 2.08e-04 | 718 | 264 | 22 | int:CSNK2A2 |
| Interaction | C9orf78 interactions | MATR3 MED14 ZMYM2 CEP170 WDR3 VPS33B ANAPC2 CLTC TIMELESS HSPA5 DYNC1H1 DYNC1LI2 HSP90AB1 COG7 ECPAS RAB3GAP1 CDK5RAP3 ATP6V0D1 LTN1 HCFC1 | 2.08e-04 | 620 | 264 | 20 | int:C9orf78 |
| Interaction | MATN4 interactions | 2.09e-04 | 23 | 264 | 4 | int:MATN4 | |
| Interaction | STAG3 interactions | 2.09e-04 | 23 | 264 | 4 | int:STAG3 | |
| Interaction | HOXD10 interactions | 2.09e-04 | 23 | 264 | 4 | int:HOXD10 | |
| Interaction | NEFM interactions | 2.12e-04 | 190 | 264 | 10 | int:NEFM | |
| Interaction | HNF1B interactions | NCOA3 POGZ TRRAP GFPT2 HSPA5 EP400 MORC4 CREBBP SMARCA2 XRCC6 | 2.12e-04 | 190 | 264 | 10 | int:HNF1B |
| Interaction | SMCHD1 interactions | 2.21e-04 | 191 | 264 | 10 | int:SMCHD1 | |
| Interaction | ATXN3 interactions | MCMBP RSF1 FAF2 NFKBIA CLTC AHCY HSPA5 DYNC1H1 HSP90AB1 USP13 POLR2A HUWE1 CREBBP ARHGDIA EIF3A XRCC6 | 2.38e-04 | 439 | 264 | 16 | int:ATXN3 |
| Interaction | RYR1 interactions | 2.38e-04 | 43 | 264 | 5 | int:RYR1 | |
| Interaction | FHL2 interactions | POGZ TOLLIP BIN1 EP400 WASHC1 NBPF6 MORC4 IFI16 CREBBP SIRT1 ZNF3 ZNF106 ANKRD17 ELF1 PBX2 | 2.46e-04 | 396 | 264 | 15 | int:FHL2 |
| Interaction | TP53BP1 interactions | NCOA3 ACTR5 RSF1 MED14 SMC5 ANAPC2 TOLLIP TADA3 EP400 POT1 HUWE1 IFI16 WDR26 CREBBP GTF3C1 PRPF38A XRCC6 SCAI | 2.50e-04 | 533 | 264 | 18 | int:TP53BP1 |
| Interaction | MYOD1 interactions | NCOA3 TRRAP RXRA EP400 HUWE1 MORC4 CREBBP SIRT1 SMARCA2 PBX1 | 2.50e-04 | 194 | 264 | 10 | int:MYOD1 |
| Interaction | MAGEA1 interactions | 2.53e-04 | 95 | 264 | 7 | int:MAGEA1 | |
| Interaction | YAP1 interactions | MCMBP MATR3 MED14 POGZ TRRAP CEP170 ZPR1 CLTC AHCY TOLLIP PLEC HSPA5 LDLRAD4 DYNC1H1 HSP90AB1 TFEB RBBP6 POLR2A OAT HUWE1 CREBBP SIRT1 GTF3C1 SMARCA2 EIF3A SCRIB PARD3 HCFC1 XRCC6 | 2.56e-04 | 1095 | 264 | 29 | int:YAP1 |
| Cytoband | 20q11.22 | 6.35e-05 | 37 | 267 | 4 | 20q11.22 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | MAP1B RYR1 PCDH11X PPP1R13B GRM5 PREX2 AKAP9 TMEM132D FARP1 PARD3 HCFC1 | 1.73e-06 | 181 | 177 | 11 | 694 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.52e-05 | 66 | 177 | 6 | 722 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.84e-04 | 3 | 177 | 2 | 287 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.70e-04 | 16 | 177 | 3 | 14 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.41e-03 | 23 | 177 | 3 | 662 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KATNB1 BCR MAP3K11 DYNC1H1 KLC1 KIF2C BIN1 ARHGAP4 ARHGDIA RAB3GAP1 FARP1 CDK5RAP2 FGD6 PCM1 | 1.72e-08 | 199 | 265 | 14 | M5893 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 MCMBP MATR3 KCMF1 RSF1 SMC5 NFKBIA SEL1L3 CRYBG1 LDLRAD4 DYNC1H1 KLC1 BIN1 RAP1GDS1 EP400 KDM5A OTUD5 RBBP6 SYNE1 USP24 HUWE1 SIK3 IFI16 WDR26 CREBBP TGFBR2 ARHGAP4 AKAP9 MYO1F SMARCA2 TNK2 ELF1 FAM53B XRCC6 PCM1 | 3.20e-06 | 1492 | 265 | 35 | M40023 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NCOA3 CLGN PNMA1 MAP1B MATR3 KCMF1 PEG3 TMOD2 COPS7A CLCN3 UCHL5 CLTC KCNMA1 PLCB4 DYNC1H1 HSP90AB1 PRUNE2 PATL1 HUWE1 ECPAS MADD ZNF106 RAB3GAP1 GTF3C1 CYP2U1 PCM1 | 4.30e-06 | 946 | 265 | 26 | M39169 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | CAAP1 ANKS6 ACTR5 PEG3 ATP9B POGZ SMC5 HELB NELL1 SVIL SEL1L3 NFYA KCNMA1 PRUNE2 SASH1 MCFD2 OLFML2B OAT CREBBP SMARCA2 DNM3 ANKRD17 EIF3A PBX1 PARD3 PCM1 HELLS | 4.55e-06 | 1009 | 265 | 27 | M157 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | MAP3K5 TFEB BIN1 SASH1 HUWE1 SIK3 TGFBR2 CELSR1 AKAP9 LTK DOP1A | 5.45e-06 | 196 | 265 | 11 | M5381 |
| Coexpression | GSE27786_NKTCELL_VS_MONO_MAC_UP | TTC39B SMC5 DDX54 GMDS BIN1 HUWE1 ECE1 ARHGDIA TIMM10 EIF3A SCAI | 6.61e-06 | 200 | 265 | 11 | M4870 |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN | FYCO1 BCR PCDH11X TOLLIP LDLRAD4 CACNB2 MCFD2 WDR26 IGFBP4 MYO1F XRCC6 | 6.61e-06 | 200 | 265 | 11 | M9957 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 SPAST MAP1B ZMYM2 ARHGAP11A SMC5 TRRAP CEP170 PLCB4 KLC1 USP13 SASH1 KDM5A USP24 SIK3 CREBBP TGFBR2 RAB3GAP1 AKAP9 LTN1 SMARCA2 ANKRD17 EIF3A PARD3 | 7.34e-06 | 856 | 265 | 24 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.12e-05 | 137 | 265 | 9 | M39241 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | TEKT3 IFT140 CLUAP1 CLGN PNMA1 ARMC3 MAP1B KATNB1 C8orf34 TSTD1 DNAAF5 DNAH9 LDLRAD4 PRUNE2 SRA1 COG7 SYNE1 DNAH7 AK8 ZNF3 C20orf96 DYDC1 ZNF106 ATP6V0D1 AKAP9 PCM1 AHNAK2 | 1.90e-05 | 1093 | 265 | 27 | M41649 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | MAP1B PEG3 TMOD2 SRPK1 RXRA RYR1 MAP3K5 CLCN3 PTPRG PLEC BRAT1 RBBP6 IFI16 ITIH5 TGFBR2 ZNF106 MOB1A CD74 EIF3A HCFC1 | 2.73e-05 | 690 | 265 | 20 | M12224 |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP | TMOD2 DNAAF5 GFPT2 SLC27A5 KIF2C PRUNE2 CACNB2 CARMIL1 MYOM2 PBX2 | 3.77e-05 | 199 | 265 | 10 | M5323 |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | SVIL ANAPC2 CRYBG1 HERC3 KLC1 POLR2A USP24 EIF3A LTBP3 DOP1A | 3.93e-05 | 200 | 265 | 10 | M9889 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 4.89e-05 | 165 | 265 | 9 | M8121 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 5.13e-05 | 166 | 265 | 9 | M344 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | DOHH MCMBP KATNB1 SRPK1 ARHGAP11A SMC5 BCR PMPCA UCHL5 NAE1 ANAPC2 AHCY TIMELESS BRAT1 KIF2C USP13 LCORL APEH OAT AAGAB GMNN GMCL1 TIMM10 THOP1 ASF1B LRRCC1 CDK5RAP2 CPSF3 HCFC1 HELLS | 5.57e-05 | 1363 | 265 | 30 | M45782 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 POGZ SMC5 MAP3K5 CEP170 NFYA KDM5A USP24 CREBBP AKAP9 ELF1 DOP1A | 6.04e-05 | 300 | 265 | 12 | M8702 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR | 6.47e-05 | 22 | 265 | 4 | M39156 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 MAP1B ZMYM2 SMC5 TRRAP CEP170 USP13 KDM5A USP24 CREBBP RAB3GAP1 AKAP9 SMARCA2 ANKRD17 PARD3 | 8.92e-05 | 466 | 265 | 15 | M13522 |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 9.98e-05 | 181 | 265 | 9 | M8662 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | TEKT3 CLUAP1 ARMC3 C8orf34 RSPH10B2 CCDC13 DNAH9 RSPH10B KIF6 GRM5 DNAH7 AK8 | 1.02e-04 | 317 | 265 | 12 | M40298 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | SPAST MAP1B PEG3 TMOD2 RYR2 NELL1 MMP24 KCNMA1 PLCB4 KLC1 GRM5 AKAP9 DNM3 ERC2 TNK2 SNAP25 MAB21L1 DOP1A SCAI | 1.09e-04 | 703 | 265 | 19 | M39070 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.62e-04 | 193 | 265 | 9 | M6813 | |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN | 1.69e-04 | 194 | 265 | 9 | M4683 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | SRPK1 TRRAP WDR3 DNAAF5 NAE1 DGUOK AHCY TIMELESS KIF2C HSP90AB1 USP24 HUWE1 ECPAS SCRIB XRCC6 PCM1 SNX5 | 1.82e-04 | 612 | 265 | 17 | M4772 |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 1.82e-04 | 196 | 265 | 9 | M6129 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.82e-04 | 196 | 265 | 9 | MM667 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 1.96e-04 | 198 | 265 | 9 | M7219 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | PHF21B POLR2A PPP1R13B TSEN2 ZNF106 RAB3GAP1 OR12D2 PBX1 SNX5 | 1.96e-04 | 198 | 265 | 9 | M6230 |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 2.04e-04 | 199 | 265 | 9 | M3417 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.04e-04 | 199 | 265 | 9 | M1746 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 2.04e-04 | 199 | 265 | 9 | M7651 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | TIMELESS HERC3 HSP90AB1 RAP1GDS1 OLFML2B GRIK5 IFIT1 CD74 PBX2 | 2.04e-04 | 199 | 265 | 9 | M5268 |
| Coexpression | GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP | 2.04e-04 | 199 | 265 | 9 | M5404 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_DN | TTC39B PPP1R13B RENBP SIK3 TGFBR2 RAB3GAP1 AKAP9 CDK5RAP2 LTK | 2.12e-04 | 200 | 265 | 9 | M5963 |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 2.12e-04 | 200 | 265 | 9 | M5986 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 2.12e-04 | 200 | 265 | 9 | M5991 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | ACTR5 CLCN3 ASPSCR1 PLEC CARMIL1 SPTLC1 RAB3GAP1 ANTKMT DOP1A | 2.12e-04 | 200 | 265 | 9 | M8038 |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 2.12e-04 | 200 | 265 | 9 | M387 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 2.12e-04 | 200 | 265 | 9 | M4817 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 2.12e-04 | 200 | 265 | 9 | M8485 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 2.12e-04 | 200 | 265 | 9 | M8480 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_DN | 2.12e-04 | 200 | 265 | 9 | M5748 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 2.12e-04 | 200 | 265 | 9 | M4456 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 2.12e-04 | 200 | 265 | 9 | M3067 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | MAP1B PEG3 TMOD2 SRPK1 RXRA RYR1 MAP3K5 CLCN3 PTPRG PLEC BRAT1 RBBP6 ITIH5 TGFBR2 ZNF106 MOB1A CD74 EIF3A HCFC1 | 2.13e-04 | 741 | 265 | 19 | MM1037 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | DOHH SPAST SMC5 BCR RSU1 TIAM2 CCDC13 PTPRG UCHL5 PYCR1 TOLLIP TADA3 WASHC1 SPTLC1 PPP1R13B SIK3 AAGAB TGFBR2 WASH3P ATP6V0D1 ASF1B FARP1 LTBP3 FGD6 DKK3 SNX5 | 2.22e-04 | 1198 | 265 | 26 | MM1062 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | IFT140 PDE4A MAP3K5 SVIL BIN1 SASH1 KDM5A SYNE1 IFI16 MADD RAB3GAP1 CDK5RAP3 GTF3C1 FARP1 SMARCA2 SCRIB | 2.36e-04 | 567 | 265 | 16 | M16909 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | DOHH SPAST SMC5 BCR RSU1 TIAM2 CCDC13 PTPRG UCHL5 PYCR1 TOLLIP TADA3 WASHC1 SPTLC1 PPP1R13B SIK3 AAGAB TGFBR2 ATP6V0D1 ASF1B FARP1 LTBP3 FGD6 DKK3 SNX5 | 2.39e-04 | 1136 | 265 | 25 | M2247 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | KATNB1 NFYA DDX43 PLEC TADA3 BIN1 OAT IFIT1 ATP6V0D1 DNM3 SNAP25 FGD6 DOP1A AHNAK2 | 2.77e-04 | 461 | 265 | 14 | M14127 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MAP1B PEG3 TMOD2 RYR2 NELL1 MMP24 PCDH11X KCNMA1 PHF21B KLC1 DNM3 ERC2 SNAP25 SCAI | 3.02e-04 | 465 | 265 | 14 | M39066 |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 PTPRG ASPSCR1 PLCB4 FRAS1 RASGRF2 MYH7B CARMIL1 FARP1 GREB1 SNAP25 | 1.79e-08 | 186 | 267 | 11 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 PTPRG ASPSCR1 PLCB4 FRAS1 RASGRF2 MYH7B CARMIL1 FARP1 GREB1 SNAP25 | 1.79e-08 | 186 | 267 | 11 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | C8orf34 GMDS PRUNE2 SASH1 SYNE1 GRM5 CELSR1 TMEM132D FARP1 DNM3 PARD3 | 2.00e-08 | 188 | 267 | 11 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PI4K2B MATR3 PEG3 GFPT2 HSPA5 OLFML2B OAT ITIH5 FRMD6 EIF3A LTBP3 | 3.07e-08 | 196 | 267 | 11 | 66d76249bd2770cdddff2c1fe59a016e95da2124 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PI4K2B MATR3 PEG3 GFPT2 HSPA5 OLFML2B OAT ITIH5 FRMD6 EIF3A LTBP3 | 3.07e-08 | 196 | 267 | 11 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MAP1B PEG3 RYR2 PTPRR PCDH11X KCNMA1 SYNE1 GRM5 ERC2 SNAP25 SCAI | 3.41e-08 | 198 | 267 | 11 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | MAP1B RYR2 SVIL KCNMA1 PRUNE2 CACNB2 SYNE1 SELENOM FRMD6 LTBP3 DKK3 | 3.78e-08 | 200 | 267 | 11 | c5e051f1aac8dda376c342a9932785a23450e073 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | BCR PTPRG PLCB4 SASH1 RASGRF2 SYNE1 PREX2 ITIH5 FRMD6 PARD3 FGD6 | 3.78e-08 | 200 | 267 | 11 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | C8orf34 SEL1L3 GMDS PRUNE2 SASH1 SYNE1 GRM5 TMEM132D DNM3 PARD3 | 1.17e-07 | 176 | 267 | 10 | 327a3e81b724252e36d786de92a3ffd721ea6d7b |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MAP1B MED14 TMOD2 NFYA TIMELESS PHF21B GMNN TIMM10 ASF1B HELLS | 1.17e-07 | 176 | 267 | 10 | a9e77681bcd36c382d53eb6f771349d55f98d744 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-07 | 178 | 267 | 10 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARMC3 C8orf34 SEL1L3 GMDS PRUNE2 SASH1 GRM5 TMEM132D FARP1 PARD3 | 1.60e-07 | 182 | 267 | 10 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NELL1 KCNMA1 LDLRAD4 PRUNE2 CACNB2 OLFML2B SYNE1 LTBP3 PBX1 DKK3 | 1.86e-07 | 185 | 267 | 10 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-07 | 188 | 267 | 10 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-07 | 188 | 267 | 10 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-07 | 188 | 267 | 10 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAP1B PEG3 RYR2 KCNMA1 PRUNE2 CACNB2 OLFML2B SYNE1 PBX1 DKK3 | 2.50e-07 | 191 | 267 | 10 | 08042952431ca1a6fd7dfc13f36eb28643979598 |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 192 | 267 | 10 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-07 | 193 | 267 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-07 | 193 | 267 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-07 | 193 | 267 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TMOD2 RYR2 KCNMA1 PLCB4 PRUNE2 CACNB2 GRIK5 ITIH5 MYOM2 RINL | 3.49e-07 | 198 | 267 | 10 | d1827e3707b929e3a3562989a0c11537d344e164 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MAP1B SVIL KCNMA1 HSP90AB1 PRUNE2 SYNE1 SELENOM LTBP3 PBX1 DKK3 | 3.65e-07 | 199 | 267 | 10 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | RYR2 SVIL KCNMA1 PRUNE2 CACNB2 SYNE1 SELENOM FRMD6 LTBP3 DKK3 | 3.83e-07 | 200 | 267 | 10 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TEKT3 ARMC3 RSPH10B2 CCDC13 DNAH9 RSPH10B KIF6 AK8 DYDC1 BEST4 | 3.83e-07 | 200 | 267 | 10 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | MAP1B SVIL KCNMA1 HSP90AB1 PRUNE2 OLFML2B SYNE1 SELENOM LTBP3 DKK3 | 3.83e-07 | 200 | 267 | 10 | 593bf6a7c557437db9a9249a5058a46014179ef6 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MAP1B RYR2 KCNMA1 PRUNE2 CACNB2 OLFML2B SYNE1 FRMD6 LTBP3 DKK3 | 3.83e-07 | 200 | 267 | 10 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.99e-07 | 121 | 267 | 8 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 181 | 267 | 9 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRG PRUNE2 FRAS1 SASH1 SYNE1 PPP1R13B DNAH7 TMEM132D FARP1 | 1.93e-06 | 186 | 267 | 9 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 186 | 267 | 9 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-06 | 189 | 267 | 9 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 189 | 267 | 9 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 191 | 267 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 191 | 267 | 9 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 267 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 267 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.09e-06 | 197 | 267 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-06 | 197 | 267 | 9 | 05e303fff86db31f7b742324c64980eb2b9cff9a | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.09e-06 | 197 | 267 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-06 | 197 | 267 | 9 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-06 | 198 | 267 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-06 | 198 | 267 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.22e-06 | 198 | 267 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 3.22e-06 | 198 | 267 | 9 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-06 | 200 | 267 | 9 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.50e-06 | 200 | 267 | 9 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-06 | 200 | 267 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.50e-06 | 200 | 267 | 9 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.50e-06 | 200 | 267 | 9 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.94e-06 | 161 | 267 | 8 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.51e-06 | 163 | 267 | 8 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.05e-06 | 120 | 267 | 7 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.12e-06 | 168 | 267 | 8 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 177 | 267 | 8 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 179 | 267 | 8 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-05 | 179 | 267 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 181 | 267 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.45e-05 | 182 | 267 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 183 | 267 | 8 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 183 | 267 | 8 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 183 | 267 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 184 | 267 | 8 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-05 | 184 | 267 | 8 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 184 | 267 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-05 | 185 | 267 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.64e-05 | 185 | 267 | 8 | 46f4f6f20b1e152922f6f2ba1244c56e48a49b79 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 186 | 267 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 1.70e-05 | 186 | 267 | 8 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 187 | 267 | 8 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.84e-05 | 188 | 267 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 188 | 267 | 8 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 188 | 267 | 8 | 15146fd2c5592ea84d20b1fdd172b39cd60b5bed | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-05 | 188 | 267 | 8 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 189 | 267 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 189 | 267 | 8 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.98e-05 | 190 | 267 | 8 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.06e-05 | 191 | 267 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.14e-05 | 192 | 267 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 2.22e-05 | 193 | 267 | 8 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 193 | 267 | 8 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.30e-05 | 194 | 267 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.30e-05 | 194 | 267 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.30e-05 | 194 | 267 | 8 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 194 | 267 | 8 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.39e-05 | 195 | 267 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.39e-05 | 195 | 267 | 8 | febe746099964b9ea9e75f2efc72c962c01f0421 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.39e-05 | 195 | 267 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 195 | 267 | 8 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 195 | 267 | 8 | 7a5108335353ac160b684650c5da97d6f7f4dbcf | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | MAP1B ZMYM2 ATP9B NT5C UCHL5 ANAPC2 BIN1 EP400 ECE1 MADD FARP1 HCFC1 DOP1A | 6.12e-07 | 198 | 265 | 13 | 7244_DN |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HG-U133A | KATNB1 VPS33B HSPA5 DNASE1L2 BIN1 SASH1 HUWE1 OSBP RAB3GAP1 AKAP9 CDK5RAP2 DOP1A | 2.64e-06 | 191 | 265 | 12 | 381_UP |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; HL60; HT_HG-U133A | NCOA3 DOHH ATP9B NFYA MTHFD2L ASPSCR1 DYNC1H1 IFIT1 TGFBR2 RAB3GAP1 THOP1 SMARCA2 | 3.45e-06 | 196 | 265 | 12 | 2924_DN |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A | DOHH ACTR5 ATP9B LRCH1 PLEC SASH1 SPTLC1 ECE1 THOP1 SMARCA2 GREB1 HELLS | 4.04e-06 | 199 | 265 | 12 | 5288_DN |
| Disease | MiT family translocation renal cell carcinoma | 2.31e-05 | 7 | 260 | 3 | C4518356 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 3.67e-05 | 8 | 260 | 3 | C3891448 | |
| Disease | vital capacity | NCOA3 CLUAP1 C8orf34 RYR2 TIAM2 CCNYL1 GMDS ASPSCR1 LCORL MYH7B SYNE1 ZKSCAN2 APOB AAGAB WDR26 ZNF106 CDK5RAP3 ZNF341 MYO1F SMARCA2 DNM3 ERC2 LTBP3 PBX1 PARD3 DKK3 | 4.05e-05 | 1236 | 260 | 26 | EFO_0004312 |
| Disease | level of Diacylglycerol (16:0_18:2) in blood serum | 7.73e-05 | 2 | 260 | 2 | OBA_2045168 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 7.75e-05 | 10 | 260 | 3 | OBA_2045163 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.06e-04 | 11 | 260 | 3 | OBA_2045170 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.24e-04 | 55 | 260 | 5 | EFO_0022234 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.31e-04 | 3 | 260 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.31e-04 | 3 | 260 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | triacylglycerol 52:3 measurement | 2.85e-04 | 15 | 260 | 3 | EFO_0010415 | |
| Disease | suntan | 3.09e-04 | 103 | 260 | 6 | EFO_0004279 | |
| Disease | sexual dimorphism measurement | B3GNT4 TTC39B MMP24 PTPRG PMPCA ZPR1 AHCY MAP3K11 GMDS PLEC LCORL POLR2A APOB SIK3 MADD IGFBP4 ZNF341 MYO1F DNM3 ERC2 FAM53B LTBP3 | 3.49e-04 | 1106 | 260 | 22 | EFO_0021796 |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.55e-04 | 195 | 260 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | ACTR5 TIAM2 FSIP2 NELL1 PTPRG KCNMA1 GFPT2 DNAH9 LDLRAD4 KIF6 FRAS1 SYNE1 CARMIL1 THAP9 PBX1 | 4.32e-04 | 619 | 260 | 15 | EFO_0003923, EFO_0004531 |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 4.59e-04 | 4 | 260 | 2 | C0410204 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 4.59e-04 | 4 | 260 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | neuroimaging measurement | MAP1B BCR LRCH1 NELL1 AHCY MAP3K11 PLEC CACNB2 KIF6 LCORL CARMIL1 PDCL2 ITIH5 ZNF106 CELSR1 SMARCA2 ERC2 FAM53B PARD3 FGD6 SCAI | 5.59e-04 | 1069 | 260 | 21 | EFO_0004346 |
| Disease | cholesterol in large HDL measurement | 7.17e-04 | 80 | 260 | 5 | EFO_0021900 | |
| Disease | Nasopharyngeal carcinoma | 9.20e-04 | 22 | 260 | 3 | C2931822 | |
| Disease | phospholipids:total lipids ratio | 9.62e-04 | 227 | 260 | 8 | EFO_0020946 | |
| Disease | initial pursuit acceleration | 1.05e-03 | 87 | 260 | 5 | EFO_0008434 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.13e-03 | 6 | 260 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Aplasia Cutis Congenita | 1.13e-03 | 6 | 260 | 2 | C0282160 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.22e-03 | 90 | 260 | 5 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Uterine leiomyoma | 1.28e-03 | 91 | 260 | 5 | HP_0000131 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.32e-03 | 54 | 260 | 4 | EFO_0022244 | |
| Disease | triglycerides in very large HDL measurement | 1.41e-03 | 55 | 260 | 4 | EFO_0022324 | |
| Disease | Malignant neoplasm of breast | NCOA3 SPAST MED14 ARHGAP11A OTOF NFKBIA TIMELESS DNAH9 KIF6 RASGRF2 SYNE1 SPTLC1 SIK3 SIRT1 ARHGDIA AKAP9 FARP1 CD74 CPSF3 DOP1A | 1.44e-03 | 1074 | 260 | 20 | C0006142 |
| Disease | major depressive disorder, COVID-19 | 1.51e-03 | 26 | 260 | 3 | MONDO_0002009, MONDO_0100096 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 1.51e-03 | 26 | 260 | 3 | OBA_2045194 | |
| Disease | Colorectal Carcinoma | MAP1B PEG3 C8orf34 NT5C NELL1 MYLK3 PCDH11X CACNB2 RASGRF2 SYNE1 APOB PREX2 TGFBR2 OSBP AKAP9 | 1.53e-03 | 702 | 260 | 15 | C0009402 |
| Disease | cholesteryl ester 16:2 measurement | 1.58e-03 | 7 | 260 | 2 | EFO_0021435 | |
| Disease | Liver neoplasms | 1.67e-03 | 142 | 260 | 6 | C0023903 | |
| Disease | Malignant neoplasm of liver | 1.67e-03 | 142 | 260 | 6 | C0345904 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.79e-03 | 144 | 260 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.83e-03 | 59 | 260 | 4 | EFO_0022248 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.95e-03 | 60 | 260 | 4 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.95e-03 | 60 | 260 | 4 | EFO_0022237 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.95e-03 | 60 | 260 | 4 | EFO_0022282 | |
| Disease | Bone neoplasms | 2.09e-03 | 8 | 260 | 2 | C0005967 | |
| Disease | Malignant Bone Neoplasm | 2.09e-03 | 8 | 260 | 2 | C0279530 | |
| Disease | NRF2 measurement | 2.09e-03 | 8 | 260 | 2 | EFO_0009794 | |
| Disease | Intellectual Disability | MAP1B ZMYM2 POGZ TRRAP PYCR1 DYNC1H1 KDM5A SYNE1 WDR26 TSEN2 MAB21L1 | 2.20e-03 | 447 | 260 | 11 | C3714756 |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.53e-03 | 31 | 260 | 3 | EFO_0022249 | |
| Disease | non-melanoma skin carcinoma | 2.54e-03 | 265 | 260 | 8 | EFO_0009260 | |
| Disease | diastolic blood pressure, systolic blood pressure | MAP1B LRCH1 RYR2 SVIL GMDS KLC1 CACNB2 CARMIL1 CHMP4B DNAH7 FARP1 FAM53B CPSF3 PCM1 | 2.66e-03 | 670 | 260 | 14 | EFO_0006335, EFO_0006336 |
| Disease | cancer (implicated_via_orthology) | 2.72e-03 | 268 | 260 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | neutrophil count | ARMC3 POGZ MAP3K5 PMPCA MTHFD2L PLCB4 PRUNE2 BIN1 OLFML2B NBPF6 SIK3 IFI16 WDR26 CREBBP GSTT2B PREX2 SIRT1 CDK5RAP3 GTF3C1 DNM3 FAM53B PBX1 HELLS | 2.74e-03 | 1382 | 260 | 23 | EFO_0004833 |
| Disease | total lipids in very large HDL measurement | 2.77e-03 | 66 | 260 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 2.77e-03 | 66 | 260 | 4 | EFO_0022298 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.92e-03 | 67 | 260 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Microlissencephaly | 3.03e-03 | 33 | 260 | 3 | C1956147 | |
| Disease | cholesterol in very large HDL measurement | 3.25e-03 | 69 | 260 | 4 | EFO_0022229 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.26e-03 | 276 | 260 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | Bone Diseases | 3.32e-03 | 10 | 260 | 2 | C0005940 | |
| Disease | Prescription Drug Abuse | 3.57e-03 | 115 | 260 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.57e-03 | 115 | 260 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.57e-03 | 115 | 260 | 5 | C0029231 | |
| Disease | Drug habituation | 3.57e-03 | 115 | 260 | 5 | C0013170 | |
| Disease | Drug abuse | 3.57e-03 | 115 | 260 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 3.57e-03 | 115 | 260 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.57e-03 | 115 | 260 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.57e-03 | 115 | 260 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.57e-03 | 115 | 260 | 5 | C0038586 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 3.60e-03 | 71 | 260 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.68e-03 | 222 | 260 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | Substance abuse problem | 3.71e-03 | 116 | 260 | 5 | C0740858 | |
| Disease | brain measurement, neuroimaging measurement | LRCH1 NELL1 PLEC CACNB2 KIF6 PDCL2 ITIH5 SMARCA2 ERC2 FAM53B PARD3 FGD6 | 3.74e-03 | 550 | 260 | 12 | EFO_0004346, EFO_0004464 |
| Disease | phosphatidylcholine measurement | 3.87e-03 | 284 | 260 | 8 | EFO_0010226 | |
| Disease | coenzyme Q10 measurement | 3.90e-03 | 36 | 260 | 3 | EFO_0007836 | |
| Disease | triacylglycerol 52:4 measurement | 3.90e-03 | 36 | 260 | 3 | EFO_0010416 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 3.90e-03 | 36 | 260 | 3 | EFO_0022257 | |
| Disease | cytochrome p450 3a4 measurement | 4.04e-03 | 11 | 260 | 2 | EFO_0020303 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 4.04e-03 | 11 | 260 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Situs Inversus | 4.04e-03 | 11 | 260 | 2 | C0037221 | |
| Disease | total lipids in large HDL | 4.18e-03 | 74 | 260 | 4 | EFO_0022189 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 4.21e-03 | 37 | 260 | 3 | EFO_0022252 | |
| Disease | collagen disease (implicated_via_orthology) | 4.82e-03 | 12 | 260 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 4.82e-03 | 12 | 260 | 2 | OBA_2045171 | |
| Disease | Myeloproliferative disease | 4.82e-03 | 12 | 260 | 2 | C0027022 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 4.89e-03 | 39 | 260 | 3 | EFO_0008298 | |
| Disease | triacylglycerol 50:3 measurement | 4.89e-03 | 39 | 260 | 3 | EFO_0010410 | |
| Disease | free cholesterol in large HDL measurement | 5.28e-03 | 79 | 260 | 4 | EFO_0022157 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.47e-03 | 239 | 260 | 7 | EFO_0010934 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 5.66e-03 | 13 | 260 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 5.66e-03 | 13 | 260 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 5.66e-03 | 13 | 260 | 2 | C0410203 | |
| Disease | illegal drug consumption | 5.66e-03 | 13 | 260 | 2 | EFO_0005431 | |
| Disease | Myopathy, Centronuclear, 1 | 5.66e-03 | 13 | 260 | 2 | C4551952 | |
| Disease | Cakut | 5.66e-03 | 13 | 260 | 2 | C1968949 | |
| Disease | sterol measurement | 5.66e-03 | 13 | 260 | 2 | EFO_0010231 | |
| Disease | Congenital Structural Myopathy | 5.66e-03 | 13 | 260 | 2 | C0752282 | |
| Disease | cervical carcinoma | 5.66e-03 | 182 | 260 | 6 | EFO_0001061 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.98e-03 | 243 | 260 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 6.03e-03 | 42 | 260 | 3 | EFO_0022255 | |
| Disease | triglycerides in large LDL measurement | 6.44e-03 | 43 | 260 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 6.44e-03 | 43 | 260 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 6.44e-03 | 43 | 260 | 3 | EFO_0022290 | |
| Disease | Tubular Aggregate Myopathy | 6.56e-03 | 14 | 260 | 2 | C0410207 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.56e-03 | 14 | 260 | 2 | EFO_0004611, EFO_0008589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVMLPDNQSLAEDEF | 1246 | P23470 | |
| QALVEENIISPMEDS | 266 | O75528 | |
| NLRMSDDPEQSLQVE | 381 | Q8NFU0 | |
| AEFEMTLERDVLQPL | 121 | Q6ZT62 | |
| LENPNSEEVEARKMI | 506 | Q5SW79 | |
| PSQLEELADFMEQLT | 2146 | Q96L91 | |
| DQEPEAVLAMLRSLD | 766 | Q6PJG6 | |
| DPENEELMLNISSRL | 1836 | Q99996 | |
| EGPENMVRIALQLDD | 86 | Q9BZE9 | |
| SNVMEDERQLGDPAI | 16 | P32519 | |
| EESNLLIQMSAVPLE | 366 | P83436 | |
| IEEERPQDRDNMVLI | 716 | Q9UJX6 | |
| LLDMPNVRELAESDF | 46 | Q9UBW8 | |
| MSAIPAEESDQLLIR | 1 | Q9UKF6 | |
| DDMFIQNLADPVVIT | 2656 | Q8IZF6 | |
| DLSFQMVDELEAVPN | 761 | P11274 | |
| RGMEVQDDLEQAAEP | 351 | Q7LC44 | |
| AQMENPDLDLEEQQR | 116 | Q969M2 | |
| REENDADPLAAEMLQ | 276 | Q49A92 | |
| LAEVFEQEIDPVMQS | 1181 | Q92793 | |
| ALMNIPVLVLDVNDD | 241 | Q16854 | |
| MVVSDFDLPDQQIEI | 1091 | Q5JWR5 | |
| ELDVMNSVIAQLAPE | 106 | Q5W041 | |
| LEQLEPSLEDVESMN | 396 | Q9H9F9 | |
| PSAQQLELLELEMRA | 331 | Q9H8G2 | |
| TPQEAIQRLRDTEEM | 21 | Q9H444 | |
| LDNNRPLEALMEVSV | 1166 | Q9NYQ6 | |
| ILDQDDLENPMLETA | 136 | O75179 | |
| ELFLNMENNEETRPV | 511 | Q8N865 | |
| ILADRMEDLTNPEDI | 256 | Q14692 | |
| ISDREMPEDLALESN | 66 | Q8N7R7 | |
| KERVAAAMENPNLRE | 136 | Q9H5X1 | |
| QDARAIPMLVDVLQD | 66 | Q9BU89 | |
| DVLQDTRQEPMVRHE | 76 | Q9BU89 | |
| NPRVELTLSELQDMA | 121 | Q96KQ4 | |
| SQPEAMDDFIREVNA | 166 | Q07912 | |
| LEAQPTDMRALQDFE | 386 | Q07912 | |
| PTAAAAVAQEIQMEL | 11 | Q08289 | |
| MEQDDPVEALTELRE | 1 | Q9BQD7 | |
| RLLAEMDIQTQEAPS | 1746 | Q96SN8 | |
| MLRAEQDSEVGPQEI | 371 | Q96IK5 | |
| DPLSSERAEMNILEI | 6 | Q96M43 | |
| ELLEDVVPQSMQDLL | 91 | Q15042 | |
| LDAVREMNDLPDTQV | 81 | Q8TCD5 | |
| RELQSMADQEQVSPA | 266 | P32322 | |
| QLAENNPFLMDDIER | 261 | Q6ZNQ3 | |
| EEEIEQMLVNDQLIP | 426 | O94822 | |
| MDRILSANNDIPVEE | 466 | P0C881 | |
| MDRILSANNDIPVEE | 466 | B2RC85 | |
| EVDQLSLPQELMAEA | 1581 | P51610 | |
| RLPQDDVDIMVTIND | 581 | Q9Y5R2 | |
| ENELEDPAIMRAVQT | 96 | Q86TB9 | |
| QEEEPTDPQLMRLDN | 96 | P40424 | |
| PARQDMEKERETLQA | 6 | P51606 | |
| IDQFEENMPVLRAEV | 306 | Q9NUD7 | |
| ENMPVLRAEVEELQA | 311 | Q9NUD7 | |
| VDSEDLPLNISREML | 381 | P08238 | |
| QEEEPVDPQLMRLDN | 106 | P40425 | |
| ITPAMLEEEEQLEAA | 26 | Q9NRZ9 | |
| ITTQMLDIRDDDNPQ | 1236 | Q86XX4 | |
| VVPSDAQQARAMVDI | 191 | P41594 | |
| LQELSPAEEEALRMD | 306 | Q86XE5 | |
| MVQSEDDARQDIIPD | 986 | Q8WXG6 | |
| DVSMVDPEALAIEQN | 2216 | P46821 | |
| QEPNMLLESEDELLV | 646 | P43243 | |
| VNDQMEERPICTQDL | 86 | Q96LZ2 | |
| LDEPMFSDIALNIDQ | 161 | Q8WWB3 | |
| ADPDAEDASNIMRVI | 496 | Q12791 | |
| SEQAPLMSEDELINI | 106 | Q8NI22 | |
| LMLQNDEPEDFVIAT | 261 | O60547 | |
| AVTMERFEPQINAEE | 481 | Q14409 | |
| VQLAADQVPLMEDLE | 446 | Q4ZG55 | |
| DQVPLMEDLEQIFLR | 451 | Q4ZG55 | |
| RASEDQDIEFQMQIP | 76 | Q86UX2 | |
| ESMLQPLAQELEATR | 341 | Q9BQS8 | |
| HDSMNDEVNPRRVLE | 276 | Q15034 | |
| EDQLQADVRPTLEML | 741 | O43861 | |
| QEEQEGPLDLTVNRM | 206 | Q8N3X6 | |
| IPQQAELVDEDAMSQ | 476 | Q9BVA0 | |
| DVEPDTREMVRAQNK | 76 | Q8TDD1 | |
| SNVQEELDRMTRKPD | 466 | O43237 | |
| EDNAESMQLEPIENL | 5176 | Q5CZC0 | |
| AIPNMDRETQEEFLV | 211 | Q86UP0 | |
| AENFSMDPQLERQVE | 646 | Q9UQ16 | |
| MSEQQDLERNADTLP | 771 | Q5VYK3 | |
| SPQDELDFLMEALII | 551 | P29376 | |
| EEVQEQRPSLDLAKM | 286 | Q14153 | |
| QNRLMVPEDISELET | 201 | Q96MA6 | |
| LEDQIIEANPAMEAF | 261 | A7E2Y1 | |
| LARDPQQEPMEEIEN | 261 | Q15154 | |
| AIQTDLEENPRKDMV | 201 | Q8N4E4 | |
| PEVLELVRAMQQDAA | 91 | Q32MK0 | |
| PAQESLEVMAQEASL | 756 | P27815 | |
| MPDQQEEKLRSQLEE | 631 | Q6ZMV9 | |
| MIEQLREAVDLLQDP | 451 | Q9Y2L9 | |
| QLTLENLQMLPESED | 271 | P25963 | |
| IEDDSRMNPEFADQI | 691 | O15083 | |
| PALESFMDQDRIVAI | 261 | P58182 | |
| PARAMVLVNVTDVND | 336 | Q9BZA7 | |
| ETSDELQEMQLPLIL | 196 | A1L453 | |
| QVPEEKVERNRTAMD | 126 | P0CG30 | |
| ESQEDVLMDEAPSNL | 2376 | Q7Z6Z7 | |
| LQANREDSMNILDPE | 2396 | Q7Z6Z7 | |
| NEPLSMLQRLTEDLE | 441 | P22059 | |
| AEQLEEVMRELAPEL | 511 | P29375 | |
| DLLEQSQMAEEAIIP | 1251 | Q9GZU2 | |
| PDLQMDIVTELDLVN | 26 | Q92832 | |
| DDEMRRLNIPVLQDD | 411 | Q86U44 | |
| NDNTAPAEDVIIMIQ | 1301 | Q7Z6E9 | |
| ADREDSPAMALLLQQ | 576 | O60244 | |
| AQPLLQLMLDVEEDR | 561 | Q15256 | |
| LDDPEFADIMLRAEQ | 101 | Q8TCG2 | |
| QESLDRENPQDFIDM | 306 | Q7Z449 | |
| DPRDLEQMNEESLEV | 461 | Q96NE9 | |
| MNESASQEELRPAQE | 1 | A4FU69 | |
| SEPINIIDALEMRDA | 2031 | P04114 | |
| NMDRLEAIETQDPSL | 156 | Q9NVP2 | |
| VRDPDLSAVSALMEQ | 61 | Q92874 | |
| DDPSRAIQTLQMELQ | 301 | O94808 | |
| LQIPDLQLEEALETM | 381 | Q8IVS8 | |
| LQAIMEDAELFPIDD | 291 | Q9C0J1 | |
| MAEQEPTAEQLAQIA | 1 | P52565 | |
| MVLDIEDLDNIQTPE | 111 | Q14152 | |
| MLDDTQEAFEVPQRA | 46 | Q9Y4F1 | |
| INAAIQDMPESEEIA | 41 | Q96JB5 | |
| AQLSDVPVESQMEEL | 646 | Q8IYE1 | |
| VIMQQDADLDSAVPD | 131 | Q8WXX0 | |
| REMIFEVLAPLAEND | 241 | P52306 | |
| LATPLENRRDMEAEE | 96 | A8MZ97 | |
| PLVDDNDDILNMVIV | 146 | Q9NSG2 | |
| RDEPLDITALMAAIQ | 186 | Q68DC2 | |
| MLEEVVNPEAQRFID | 221 | P05108 | |
| AQRQCLSPEEMDVDE | 1071 | Q9NS15 | |
| PFTLVADVNADRNME | 646 | Q16666 | |
| SIDDDEMPDLENRVL | 26 | P09914 | |
| EMPDLENRVLDQIEF | 31 | P09914 | |
| EEAASPMLQIQRDAA | 2406 | Q14204 | |
| SNREAMDPIAELLSQ | 191 | Q9P0J7 | |
| VLDNLVQMIQDEESP | 531 | Q5VZK9 | |
| LDRANQSVPEDLVVM | 586 | Q86TM3 | |
| LLAAVVSMERPDLEQ | 3586 | Q9NYC9 | |
| DEEAIRPQMQQILDF | 296 | P42892 | |
| EDQKPVMDDQRDLIS | 11 | P04233 | |
| LVMPEINDKENRDVT | 806 | Q9Y4K1 | |
| SAEQIRDVQETLMPQ | 691 | Q86Y56 | |
| DQDVDTPNLDAMARD | 46 | Q6UWV6 | |
| QRMEVPVESADDLAD | 646 | Q16478 | |
| NRLTPEEIERMVNDA | 531 | P11021 | |
| FEEMNVDLQEELPSL | 216 | O00499 | |
| DEAEIEETLQAAMPQ | 31 | Q8ND90 | |
| INEEDADTMRLQPIG | 141 | Q96T23 | |
| EEQPMDLENRSTANV | 256 | Q96T23 | |
| ITEIDPINALQAAME | 241 | P23526 | |
| ANEDMPVERILEAEL | 226 | P19793 | |
| AQEDFVQSPELVRAM | 2106 | P21817 | |
| SVMDNNELALALREP | 2246 | Q92736 | |
| PQEEATLNEMFREVE | 41 | Q9UBP4 | |
| PEQVRHNSMEDAREL | 1436 | Q96RY7 | |
| RITAQENDMEVELPA | 121 | Q99661 | |
| ENDMEVELPAAANSR | 126 | Q99661 | |
| LERANQSIPEELVSM | 606 | Q9NXZ2 | |
| QEELFLDNEMSLPLE | 186 | Q8NG08 | |
| EVPLDRDQVAALEMI | 451 | Q8NG08 | |
| LEALEAQVLREMPRD | 376 | Q16584 | |
| VAEVLNDPENMEKRR | 506 | Q07866 | |
| LNNDERDASALLDPM | 271 | Q9BTE3 | |
| PVASSIDRNEMLEIQ | 51 | Q9HC10 | |
| ARIEAMDPATVEQQE | 186 | Q96G74 | |
| VNMPQDDTVIIEDDR | 751 | Q8TEW0 | |
| DEPERGMENLLEVQV | 341 | Q9BTY7 | |
| DPNQADEEAMTQIIR | 331 | P23511 | |
| TLQDIPEDFLEMDLA | 496 | O15403 | |
| MAELIERLNGEPLDN | 151 | O75496 | |
| VRNLMESLAQGAEEP | 1066 | Q99683 | |
| PQMDFLALSQELEQE | 596 | Q8IVF1 | |
| ESREKNQPEVDMSDR | 11 | Q15404 | |
| RAEQSPSMEENLSIE | 156 | Q9H7C4 | |
| MAVQFELEDLNLRPD | 186 | Q10713 | |
| AMSEREAAPNEELVQ | 266 | Q8NCE0 | |
| VENLEVENSLEPDIM | 541 | Q6P4F7 | |
| SNPERELDDVIDNIM | 151 | P19484 | |
| EMDLLTVPRNQNESV | 516 | Q68CR1 | |
| LMSDENAPVFLDRLE | 296 | Q15147 | |
| VMGQNIDEDLLREPE | 2356 | Q8WUY3 | |
| DEVPDDETLNQMIAR | 1231 | P51531 | |
| PLSEMTREEINALVQ | 96 | Q8WWX9 | |
| EDIEARPDMQLESDL | 1251 | O95425 | |
| IQDLEDIEQRVPVMD | 746 | Q8NF91 | |
| ITELINDFMQVEEPR | 606 | Q14C87 | |
| EVQEPRFISSLNEMD | 46 | Q13394 | |
| DPLSSERAEMNILEI | 6 | Q86XG9 | |
| DPLSSERAEMNILEI | 6 | Q5VWK0 | |
| MNVLNLLEEVLRDPD | 941 | O14827 | |
| LRQAVMLPEGEDLNE | 41 | Q9H8S9 | |
| FLMNDRDPEEPNLDV | 146 | Q96MH2 | |
| INSPTRNADMQEELI | 1336 | Q7Z3K3 | |
| MAAPEERDLTQEQTE | 1 | Q96CS3 | |
| ELEDQMPRLVAEESN | 661 | Q8TE76 | |
| DILEDINASPEMRQR | 206 | Q9Y6Q9 | |
| FQIPASEVLMDDDLQ | 566 | Q9NUX5 | |
| QVDPLNEDVLLAMED | 341 | Q9Y2K2 | |
| RNVESIAEQMENPDL | 586 | Q96EB6 | |
| APEVLESRMNLENVE | 426 | P37173 | |
| LERALMETEAPLQVA | 181 | Q9BXF9 | |
| LLAQEPREMTADVIE | 941 | Q9NSE4 | |
| PEVANFMQLVELDVS | 76 | Q14160 | |
| LVMGATNRPQELDEA | 481 | Q9UBP0 | |
| PNDPNREMVVQLLDD | 136 | Q96SB4 | |
| MELAEIEAIQESLQP | 101 | P22692 | |
| IEELQLFDQEPMRSL | 461 | Q9C0C4 | |
| ENILDSMPDIRSALQ | 216 | Q68BL8 | |
| PDVALLDTQDVENMS | 646 | O60518 | |
| ERALQDPNVAAFMVE | 216 | P04181 | |
| MDAAVTDDFQQILPI | 1 | O43610 | |
| EMELRDEILPRAQNI | 351 | P98171 | |
| VQQLLDDERMLVEPA | 261 | Q96GA7 | |
| AAAAIEALNIMEENP | 346 | O15269 | |
| QPARVVDEREQMAIS | 116 | P60880 | |
| MERQVLLSEPEEAAA | 1 | P13798 | |
| DAQVDSIVDPMLDLD | 231 | Q6PD74 | |
| NLDVSLPSMEVDIQA | 4421 | Q8IVF2 | |
| LVMNPDDTFEVLVDQ | 231 | O14967 | |
| QFAQMLVQDEEPLAD | 531 | Q00610 | |
| PLAVLTQDNMTVDDI | 666 | P51790 | |
| EMRTEAIARPLEINE | 166 | Q96AJ1 | |
| DTQLDVEFLMELLDP | 471 | Q6ZS11 | |
| AELQRQLAEEEPMDT | 236 | Q9Y5K5 | |
| PVEEQRAEAMVRIQD | 591 | Q9UNS1 | |
| EALALDLMEPEQAVD | 491 | P12956 | |
| RQQEEMLGLQEEAPA | 226 | O75312 | |
| VQVMALNPSRQEDEE | 391 | Q9BYN7 | |
| QTDALEPMTLQERED | 861 | Q9UPR6 | |
| METQADLVSQEPQAL | 1 | P17036 | |
| LSMLPEEDVVATNEN | 476 | Q5VTQ0 | |
| EAQLQEIEEMITAPE | 481 | Q9BUI4 | |
| EIEEMITAPERQQLE | 486 | Q9BUI4 | |
| LEPLQNETFLTQDEM | 1126 | Q8IVF5 | |
| MELQSRPEALAVELA | 1 | Q96EK2 | |
| EEQELSNMERIPSTL | 451 | Q9H5L6 | |
| LVQFDMEAAEPVRDN | 466 | Q9Y2P5 | |
| PQSLETRAEIQELAM | 506 | P24928 | |
| QPDLRREEAVQQMAD | 21 | Q6VEQ5 | |
| PREDEDLIFDIDQAM | 76 | A6NMA1 | |
| EAVMEDVLRPLEQAL | 96 | Q9HD15 | |
| FPNMDQEVIRSVLEA | 241 | Q9H0E2 | |
| QPDLRREEAVQQMAD | 21 | A8K0Z3 | |
| LVLEPLEMNENLENS | 131 | Q6ZV73 | |
| QPDLRREEAVQQMAD | 21 | C4AMC7 | |
| EADPVMVLNDDNTIV | 236 | Q8N9R8 | |
| AEDLDQPERDVAANM | 1131 | O94885 | |
| LDVSPRNLSQEESME | 201 | A6NKC9 | |
| PNLTDEQAMLEDTLV | 1326 | Q70Z35 | |
| QLEPRVSALEEDMDD | 176 | Q8NAV1 | |
| MAAVPELLQQQEEDR | 1 | Q9Y5X3 | |
| AQSDDVPVDIMDLAL | 516 | O00507 | |
| EVMQSDLIPEEQRAQ | 3726 | Q15149 | |
| DLIPEEQRAQLMADF | 3731 | Q15149 | |
| ELLDVTDQLNMDPRV | 126 | Q9H903 | |
| PRAAEELDMENEFLL | 1011 | Q9UBW7 | |
| MLEVISDAEENLIPD | 361 | Q8TCN5 | |
| MESPDEEIANEAIQL | 831 | Q9UPU5 | |
| MAVALDSQIDAPLEV | 1 | Q63HK3 | |
| MDPLRAQQLAAELEV | 1 | P62072 | |
| DLTDRNIVQEDHPIM | 516 | Q9H7D7 | |
| PEVNVEMSLQDEIQR | 341 | Q9UNX4 | |
| MDQNDPLVRSAIEQV | 696 | Q12789 | |
| MVFQDLPNTLDEIDA | 856 | Q8IY18 | |
| VERDFVEAPSQMLEN | 496 | P52888 | |
| EIISSMDNPDNEIVL | 411 | Q13564 | |
| VPENENRMEDRLAET | 326 | Q96PF2 | |
| PEEQQLSFIERLVEM | 2896 | Q9Y4A5 | |
| QLENVLDDLDPESAM | 31 | Q9NZR1 | |
| MVPLVQNEQEALDLD | 816 | Q9H2Y7 | |
| DRLMNQLIDPSDIDE | 641 | Q92995 | |
| IEADLMSPLDRIANV | 41 | Q9H267 | |
| RQAATMLEEAASPNE | 26 | Q6UXV3 | |
| LNIPVSELESALQME | 41 | Q8NFU3 | |
| EQMEAVNIAQTPAEL | 136 | P61421 | |
| NVEMDPEIQRVRAQE | 111 | Q14CN4 | |
| LRDPEQQMELNRESV | 191 | O15165 | |
| DSPLNISEDEIIDRM | 231 | Q9C099 | |
| DMVLLPQITEDAIAA | 21 | O00160 | |
| SFNVNEVIEILMEDP | 1061 | O00160 | |
| LDPEELERLMALSNE | 996 | P54296 |